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Abstract: Bei schwerer systemischer Entzündung und Sepsis finden grundlegende Veränderungen an Kom-
ponenten des Gefässsystems statt, insbesondere die entzündliche Aktivierung von Zellen der Gefässwand
wie Endothel und glatte Muskelzellen sowie die Aktivierung von Blutzellen wie Monozyten undThrom-
bozyten. Es kommt zur Ausschüttung von entzündungsfördernden Mediatoren wie Stickstoffmonoxid
NO, Zytokinen und Chemokinen wie TNF￿, IL-1, IL-6, sowie Tissue Factor (TF). Diese Faktoren sind
verantwortlich für Blutdruckabfall, Fieber und disseminierte intravasale Gerinnung, was schliesslich zu
Schock und Multiorganversagen mit hoher Mortalität führt. Ziel unserer Forschung ist es, die Entzün-
dungsprozesse in den beteiligten vaskulären Zellsystemen zu verstehen und damit Möglichkeiten einer
anti-inflammatorischen Intervention aufzuzeigen. Das Hauptziel der vorliegenden Dissertation war es,
die Antwort von Blutmonozyten auf inflammatorische Stimulation mit IFN￿ in Kombination mit einem
mikrobiellen Trigger wie Lipopolysaccharid (LPS) auf transkriptioneller Ebene zu untersuchen, um neue
Zielgene für anti-inflammatorische Interventionen mit aktiviertem Protein C (APC) zu finden. APC ist
ein körpereigener Gerinnungshemmer mit möglicherweise anti-inflammatorischen Eigenschaften. Durch
Analyse des Genexpressionsprofils von entzündlich aktivierten Monozyten konnten wir das gesamte Spek-
trum von Genen, welche an der Entzündungsantwort beteiligt sind, definieren. Eine funktionelle Cluster-
analyse zeigte eine signifikante Ueberrepresentation von entzündungsassoziierten Genen (induzierte Gene)
und Genen welche mit Lipidstoffwechselprozessen assoziiert sind (supprimierte Gene). Die anti- inflam-
matorische Wirkung von APC konnte erstmals in entzündlich aktivierten Monozyten bestätigt werden.
Ausserdem konnten wir Signalmoleküle und Transkriptionsfaktoren, welche bisher in Monozyten nicht
bekannt waren oder nicht mit Entzündungsprozessen in Verbindung gebracht werden konnten, als Angriff-
sziele von APC definieren. Unter anderen fanden wir, dass APC den Acetylierungszustand von Histonen
moduliert und somit eine Rolle im Chromatinremodeling spielt. Damit wird die Transkription bestimmter
Genabschnitte reguliert, die bei einer Entzündungsantwort von Monozyten wichtig sind. Diese Resultate
vermitteln ganz neue Einblicke für therapeutische Möglichkeiten bei schwerer systemischer Entzündung
und Sepsis. Eines der durch APC am stärksten regulierten Gene ist Wnt5A. In Makrophagen wurde
Wnt5A erst kürzlich als ein wichtiger Faktor des durch Toll-Rezeptoren vermittelten inflammatorischen
Signalwegs erkannt. Wir sahen, dass Wnt5A durch ein Tollrezeptor vermitteltes Entzündungssignal stark
heraufreguliert wird. Wnt5A wiederum induzierte die Gene für die inflammatorischen Zytokine IL-6, IL-
8, und MCP- 1 über einen Ca2+/Calmodulin abhängigen Proteinkinase II (CaMKII ) Signalweg. Dieser
Signalweg konnte durch solubles Frizzled-related Peptide 1 (sFRP1), ein lösliches Peptid welches den
Wnt5A-Signalweg moduliert, komplett gehemmt werden. Die Tatsache, dass sFRP1 auch die LPS/IFN￿
induzierte Phosphorylierung von CaMKII hemmt, deutet auf einen Zusammenhang zwischen entzün-
dungsvermittelter Freisetzung von Wnt5A und LPS/IFN￿r induzierter Aktivierung der Makrophagen hin.
Wir konnten zeigen, dass die Expression von Wnt5A ein hochkonservierter Vorgang bei der Makropha-
genaktivierung ist und ein breites Spektrum von Tollrezeptor- Liganden bei der Auslösung systemischer
Entzündungsreaktion beteiligt sind. Wir konnten weiterhin zeigen, dass die anti-inflammatorisch wirk-
samen Mediatoren IL-10 und APC diesen Effekt stark beeinflussen. In Seren von Patienten mit schw-
erer systemischer Entzündung oder septischem Schock fanden wir grosse Mengen immunpräzipitierbares
Wnt5A, ein weiterer Hinweis auf eine aktive Rolle von freigesetztem Wnt5A in der Pathophysiologie
von systemischen Entzündungsreaktionen bei Sepsis. Dass Wnt5A ein sezerniertes Entzündungsprotein
ist und sein Signal durch klassische Rezeptor-Ligand-Interaktion weitergibt, ermöglicht eine Beeinflus-
sung seiner Aktivität in vivo. Eine Möglichkeit hierfür wäre die therapeutische Anwendung löslicher
Wnt5A neutralisierender Moleküle, wie wir sie in unserer Arbeit verwendet haben, um den entzündlichen
Wnt5A-Signalweg zu hemmen. During systemic inflammation and sepsis, different components of the
vascular system are altered, especially cells of the vessel wall such as endothelium and smooth muscel
cells are inflammatory activated, as well as blood cells such as monocytes and platelets. Thereby pro-
inflammatory mediators such as nitric oxide NO, cytokines, and chemokines such as TNF￿, IL-1, IL-6,
and tissue factor were released. These factors are responsible for reduced blood pressure, fever, and dis-
seminated intravasal coagulaton, leading to shock, multiorgan failure and death. The aim of our research
is to define the processes involved in the inflammatory response of the vascular cell systems and to find
targets for anti-inflammatory intervention. The main goal of this thesis was to study the transcriptional
response of monocytes after treatment with inflammatory stimuli (stimulation with interferon (INF) fol-
lowed by exposure to a microbial trigger like lipopolysaccharide (LPS)) and define new targets for the
anti-inflammatory action of activated protein C (APC), an endogenous anti- coagulant with possible
anti-inflammatory properties. By gene expression profiling analysis of inflamed macrophages, candi-
date genes involved in inflammatory responses were defined. Functional clustering of genes significantly
regulated by inflammatory stimuli showed a significant overrepresentation of genes involved in the inflam-
matory response (upregulated genes), and genes associated with lipid metabolic processes (downregulated
genes). We were able to confirm the anti- inflammatory action of APC in inflamed macrophages, and
define signaling molecules and transcription factors not assigned to inflammatory responses as targets
for APC. Among others, we found genes that modulate the acetylation and deacetylation of histone that
were regulated by APC, indicating that APC could be involved in chromatine remodeling and thus in
transcription regulation of genes that play a role in the inflammatory response of macrophages. These
results provide novel insights for therapeutic strategies using APC in systemic inflammation and sepsis.
Among the genes most prominently regulated by APC was Wnt5A, a gene that recently emerged to be
an important factor for the Toll-mediated inflammatory signaling in macrophages. We have found that
Wnt5A was consistently upregulated via Toll-like receptor activation in inflamed monocytes. Wnt5A
in turn upregulated expression of the pro-inflammatory genes IL-6, IL-1￿, IL-8, and MCP-1 via Ca2+-
calmodulin–dependent protein kinase II (CaMKII) signaling. This effect was completely abrogated by
sFRP1, a soluble modulator of Wnt signaling. Our finding, that sFRP1 also inhibited the LPS/IFN-￿
induced CamKII phosphorylation, implied a causal link between Wnt5A secretion triggered by inflamma-
tion and LPS/IFN-￿ induced macrophage activation. We showed that expression of Wnt5A constitutes
a highly conserved response to macrophage activation triggered by a wide array of Toll ligands involved
in initiation of systemic inflammation. Attenuation of this effect was achieved by the anti-inflammatory
mediators IL-10 and APC. High levels of immunoprecipitatable Wnt5A in sera from patients with severe
sepsis provided direct evidence of an active role for secreted Wnt5A in the pathophysiology of the sys-
temic inflammatory response during sepsis. The fact that Wnt5A is a secreted inflammatory protein and
that Wnt5A signaling involves classical receptor–ligand interactions raises the possibility of modulation
of Wnt5A activity in vivo. Therapeutic application of soluble Wnt5A neutralizing molecules, as applied
in our work, thereby represents just one possibility for achieving in vivo suppression of inflammatory Wnt
signaling.
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1. Preface  
 
 
 
The work of this thesis was performed at the Department of Internal Medicine at the 
University Hospital of Zurich. The work is part of the project No. 3200B0-103945 of 
the Swiss National Science Foundation. 
 
The aim of this work was to study the transcriptional response of monocytes during 
inflammation and define new targets for the anti-inflammatory action of activated 
protein C (APC). 
 
The data is presented in form of the following publications or manuscripts submitted 
for publication: 
 
1. Analysis of the Inflammatory Transcriptome of Human Macrophages 
Revealed Unique Genes as Targets for the Anti-inflammatory Action of 
Activated Protein C 
     Pereira C, Bachli EB, Schaer DJ, Schoedon G 
     Submitted manuscript 
 
2. Wnt5A/CaMKII signaling contributes to the inflammatory response of 
macrophages and is a target for the anti-inflammatory action of activated 
protein C and interleukin-10 
     Pereira C, Schaer DJ, Bachli EB, Kurrer MO, Schoedon G 
     Arterioscler Thromb Vasc Biol, 2008. 28(3): p. 504-510. 
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2. Abbreviations 
 
 
APC  activated protein C 
COX-2  cyclooxygenase-2 
CSF   colony stimulating factor 
DIC  disseminated intravascular coagulation  
EC  endothelial cells 
EGF  epidermal growth factor  
EPCR  endothelial protein C receptor 
ICU  intensive care unit  
LBP  lipopolysaccharide binding protein  
LPS  lipopolysaccharide 
PAI-1  plasminogen activator 1 
TFPI  tissue factor pathway inhibitor 
PAR-1  protease activated receptor-1 
PAR-2  protease activated receptor-2 
PC  protein C  
PCI  protein C inhibitor  
PCP   planar cell polarity  
PROWESS Recombinant Human Activated Protein C Worldwide Evaluation in 
Severe Sepsis study group 
rAPC  recombinant activated protein C 
TAFI  thrombin-activatable fibrinolysis inhibitor  
TM  trombomodulin  
tPa  tissue plasminogen activator 
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3. Zusammenfassung 
 
 
Bei schwerer systemischer Entzündung und Sepsis finden grundlegende  
Veränderungen an Komponenten des Gefässsystems statt, insbesondere die 
entzündliche Aktivierung von Zellen der Gefässwand wie Endothel und glatte 
Muskelzellen sowie die Aktivierung von Blutzellen wie Monozyten undThrombozyten. 
Es kommt zur Ausschüttung von entzündungsfördernden Mediatoren wie 
Stickstoffmonoxid NO, Zytokinen und Chemokinen wie TNFα, IL-1, IL-6, sowie Tissue 
Factor (TF). Diese Faktoren sind verantwortlich für Blutdruckabfall, Fieber und 
disseminierte intravasale Gerinnung, was schliesslich zu Schock und 
Multiorganversagen mit hoher Mortalität führt. Ziel unserer Forschung ist es, die 
Entzündungsprozesse in den beteiligten vaskulären Zellsystemen zu verstehen und 
damit Möglichkeiten einer anti-inflammatorischen Intervention aufzuzeigen. 
Das Hauptziel der vorliegenden Dissertation war es, die Antwort von Blutmonozyten 
auf inflammatorische Stimulation mit IFNγ in Kombination mit einem mikrobiellen 
Trigger wie Lipopolysaccharid (LPS) auf transkriptioneller Ebene zu untersuchen, um 
neue Zielgene für anti-inflammatorische Interventionen mit aktiviertem Protein C 
(APC) zu finden. APC ist ein körpereigener Gerinnungshemmer mit möglicherweise 
anti-inflammatorischen Eigenschaften. Durch Analyse des Genexpressionsprofils von 
entzündlich aktivierten Monozyten konnten wir das gesamte Spektrum von Genen, 
welche an der Entzündungsantwort beteiligt sind, definieren. Eine funktionelle 
Clusteranalyse zeigte eine signifikante Ueberrepresentation von 
entzündungsassoziierten Genen (induzierte Gene) und Genen welche mit 
Lipidstoffwechselprozessen assoziiert sind (supprimierte Gene). Die anti-
inflammatorische Wirkung von APC konnte erstmals in entzündlich aktivierten 
Monozyten bestätigt werden. Ausserdem konnten wir Signalmoleküle und 
Transkriptionsfaktoren, welche bisher in Monozyten nicht bekannt waren oder nicht 
mit Entzündungsprozessen in Verbindung gebracht werden konnten, als Angriffsziele 
von APC definieren. Unter anderen fanden wir, dass APC den Acetylierungszustand 
von Histonen moduliert und somit eine Rolle im Chromatinremodeling spielt. Damit 
wird die Transkription bestimmter Genabschnitte reguliert, die bei einer 
Entzündungsantwort von Monozyten wichtig sind. 
Diese Resultate vermitteln ganz neue Einblicke für therapeutische Möglichkeiten bei 
schwerer systemischer Entzündung und Sepsis. 
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Eines der durch APC am stärksten regulierten Gene ist Wnt5A. In Makrophagen 
wurde Wnt5A  erst kürzlich als ein wichtiger Faktor des durch Toll-Rezeptoren 
vermittelten inflammatorischen Signalwegs erkannt. Wir sahen, dass Wnt5A durch ein 
Tollrezeptor vermitteltes Entzündungssignal stark heraufreguliert wird. Wnt5A 
wiederum induzierte die Gene für die inflammatorischen Zytokine IL-6, IL-8, und MCP-
1 über einen Ca2+/Calmodulin abhängigen  Proteinkinase II (CaMKII ) Signalweg. 
Dieser Signalweg konnte durch solubles Frizzled-related Peptide 1 (sFRP1), ein 
lösliches Peptid welches den Wnt5A-Signalweg moduliert, komplett gehemmt werden. 
Die Tatsache, dass sFRP1 auch die LPS/IFNγ induzierte Phosphorylierung von 
CaMKII hemmt, deutet auf einen Zusammenhang zwischen entzündungsvermittelter 
Freisetzung von Wnt5A und LPS/IFNγr induzierter Aktivierung der Makrophagen hin. 
Wir konnten zeigen, dass die Expression von Wnt5A ein hochkonservierter Vorgang 
bei der Makrophagenaktivierung ist und ein breites Spektrum von Tollrezeptor-
Liganden bei der Auslösung systemischer Entzündungsreaktion beteiligt sind.  Wir 
konnten weiterhin zeigen, dass die anti-inflammatorisch wirksamen Mediatoren IL-10 
und APC diesen Effekt stark beeinflussen. In Seren von Patienten mit schwerer 
systemischer Entzündung oder septischem Schock fanden wir grosse Mengen 
immunpräzipitierbares Wnt5A, ein weiterer Hinweis auf eine aktive Rolle von 
freigesetztem Wnt5A in der Pathophysiologie von systemischen 
Entzündungsreaktionen bei Sepsis. Dass Wnt5A ein sezerniertes Entzündungsprotein 
ist  und sein Signal durch klassische Rezeptor-Ligand-Interaktion weitergibt, 
ermöglicht eine Beeinflussung seiner Aktivität in vivo. Eine Möglichkeit hierfür wäre die 
therapeutische Anwendung löslicher Wnt5A neutralisierender Moleküle, wie wir sie in 
unserer Arbeit verwendet haben, um den entzündlichen Wnt5A-Signalweg zu 
hemmen. 
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4. Summary 
 
During systemic inflammation and sepsis, different components of the vascular 
system are altered, especially cells of the vessel wall such as endothelium and 
smooth muscel cells are inflammatory activated, as well as blood cells such as 
monocytes and platelets. Thereby pro-inflammatory mediators such as nitric oxide 
NO, cytokines, and chemokines such as TNFα, IL-1, IL-6, and tissue factor were 
released. These factors are responsible for reduced blood pressure, fever, and 
disseminated intravasal coagulaton, leading to shock, multiorgan failure and death. 
The aim of our research is to define the processes involved in the inflammatory 
response of the vascular cell systems and to find targets for anti-inflammatory 
intervention.  
The main goal of this thesis was to study the transcriptional response of monocytes 
after treatment with inflammatory stimuli (stimulation with interferon (INF) followed by 
exposure to a microbial trigger like lipopolysaccharide (LPS)) and define new targets 
for the anti-inflammatory action of activated protein C (APC), an endogenous anti-
coagulant with possible anti-inflammatory properties. By gene expression profiling 
analysis of inflamed macrophages, candidate genes involved in inflammatory 
responses were defined. Functional clustering of genes significantly regulated by 
inflammatory stimuli showed a significant overrepresentation of genes involved in the 
inflammatory response (upregulated genes), and genes associated with lipid 
metabolic processes (downregulated genes). We were able to confirm the anti-
inflammatory action of APC in inflamed macrophages, and define signaling molecules 
and transcription factors not assigned to inflammatory responses as targets for APC. 
Among others, we found genes that modulate the acetylation and deacetylation of 
histone that were regulated by APC, indicating that APC could be involved in 
chromatine remodeling and thus in transcription regulation of genes that play a role in 
the inflammatory response of macrophages. These results provide novel insights for 
therapeutic strategies using APC in systemic inflammation and sepsis. 
Among the genes most prominently regulated by APC was Wnt5A, a gene that 
recently emerged to be an important factor for the Toll-mediated inflammatory 
signaling in macrophages. We have found that Wnt5A was consistently upregulated 
via Toll-like receptor activation in inflamed monocytes. Wnt5A in turn upregulated 
expression of the pro-inflammatory genes IL-6, IL-1, IL-8, and MCP-1 via Ca2+-
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calmodulin–dependent protein kinase II (CaMKII) signaling. This effect was 
completely abrogated by sFRP1, a soluble modulator of Wnt signaling. Our finding, 
that sFRP1 also inhibited the LPS/IFN-γ induced CamKII phosphorylation, implied a 
causal link between Wnt5A secretion triggered by inflammation and LPS/IFN-γ 
induced macrophage activation. We showed that expression of Wnt5A constitutes a 
highly conserved response to macrophage activation triggered by a wide array of Toll 
ligands involved in initiation of systemic inflammation. Attenuation of this effect was 
achieved by the anti-inflammatory  mediators IL-10 and APC. High levels of 
immunoprecipitatable Wnt5A in sera from patients with severe sepsis provided direct 
evidence of an active role for secreted Wnt5A in the pathophysiology of the systemic 
inflammatory response during sepsis. The fact that Wnt5A is a secreted inflammatory 
protein and that Wnt5A signaling involves classical receptor–ligand interactions 
raises the possibility of modulation of Wnt5A activity in vivo. Therapeutic application 
of soluble Wnt5A neutralizing molecules, as applied in our work, thereby represents 
just one possibility for achieving in vivo suppression of inflammatory Wnt signaling. 
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5. Introduction 
 
5.1 The vascular system 
 
The vascular system is constituted by a complex and articulate network, e.g. arteries, 
arterioles, venules and veins, that requires a high degree of coordination between 
different elemental cell types. The endothelial cells (EC) play a pivotal role in the 
vascular homeostasis being located at the interface between blood and the 
underlying smooth muscle cells. EC regulate complex functions compliant to specific 
necessities in time and location [1].  
 
5.1.1 Immunovascular communication 
 
Inflammation is generally defined as the localized response to cellular or tissue injury 
[2]. It is clear that each type of inflammation is not a simple linear cascade but rather 
a complex highly orchestrated and fine-tuned process involving interactions between 
many different types of cells, soluble mediators and tissue matrix. Some mediators 
initiate or amplify an inflammatory process some modulate it or cause it to subside 
and a number probably can do either depending on the context in which they are 
acting. Many different cell types may participate in inflammatory processes including 
among others, phagocytic cells, dendritic cells, mast cells and basophils, endothelial 
cells, smooth muscle cells, platelets and lymphocytes. Even larger numbers of 
intercellular signaling molecules participate in various inflammatory processes, 
including immunoglobulins, arachidonic acid metabolites complement components, 
the intrinsic clotting system and coagulation factors, fibrinolytic molecules and a large 
number of cytokines and chemokines.  
Mononuclear cells play a key role in immunovascular communication by  releasing 
the classical pro-inflammatory cytokines interleukine (IL)1, IL6 and tumor necrosis 
factor (TNF), but in addition an array of other cytokines, chemokines, lipid mediators 
and reactive oxygen species. Most of these products have multiple targets and cause 
effects through several parallel mechanisms. Furthermore, many macrophage 
products are involved in the regulation of each other. Thus TNF upregulates tissue 
factor (TF), IL18 induces interferon (INF), which in turn further activates 
macrophages, while IL10 is a global suppressor of macrophage function. Bacterial 
lipopolysaccharide (LPS) in complex with LPS-binding protein (LBP) binds to 
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monocytes via CD14 and toll-like receptor 4 (TLR4). This results in activation of pro-
inflammatory and coagulation pathways. Pro-inflammatory cytokines (e.g. TNF, 
IL1) act in autocrine and paracrine loops to further activate monocytes and 
endothelial cells by upregulating adhesion molecules, cytokines, chemokines and 
growth factors. TNF and IL1 can also induce apoptosis of monocytes and 
endothelial cells. If left uncontrolled, these highly complex and tightly regulated 
networks can lead to widespread inflammation, thrombosis, cell death, organ failure, 
and ultimately death [3]. 
 
5.1.2. Inflammation and sepsis 
 
In contrast to the normal inflammatory response, sepsis is a devastating condition 
characterized by systemic activation of inflammatory and coagulation pathways in 
response to microbial infection of normally sterile parts of the body [4]. Microbial 
invasion originates from a breach of integrity of the host barrier, either physical or 
immunological. Sepsis is the leading cause of death in non-coronary intensive care 
unit (ICU) patients and is a leading cause of morbidity and mortality in the Western 
world [5]. There are several important themes in our current understanding of sepsis 
pathophysiology. First, it is rare for the initial infection to be the cause of mortality; 
rather, mortality is the result of the body’s response to infection. Although activation 
of the innate immune system is generally protective, an excessive or insufficiently 
controlled immune response may harm the host through a maladaptive release of 
inflammatory mediators. Second, monocytes and endothelial cells play a key role in 
modulating the host response to infection. As a first line of defence, monocytes 
recognize microbial products such as LPS through pattern recognition receptors (e.g. 
Tolllike receptors). The interaction of pathogens with monocyte receptors activates 
both the inflammatory and coagulation pathways. On the inflammation side, activated 
monocytes release inflammatory mediators that function in autocrine or paracrine 
loops to further activate monocytes and/or endothelial cells. The endothelium 
responds to these mediators with structural changes, such as cytoplasmic swelling 
and detachment and importantly, also with functional changes, such as the 
expression of adhesion molecules, resulting in increased platelet adhesion and 
leukocyte trafficking [1, 6]. On the coagulation side, activated monocytes and 
endothelial cells express TF on their cell surface, the “spark” that triggers blood 
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clotting [7]. Thus, monocytes and endothelial cells have the potential to inflict 
“collateral damage” to host tissues. A third theme in our understanding of sepsis 
pathophysiology is that inflammation, coagulation, and apoptosis are intimately 
linked. If left uncontrolled, the vicious cycles of inflammation and coagulation can 
lead to widespread inflammation, thrombosis, cell death, organ failure, and ultimately 
death [8, 9]. 
 
5.1.3. Inflammation, coagulation and sepsis 
 
Under normal circumstances, the natural anticoagulant mechanisms provide a potent 
defence against thrombotic complications. Inflammatory mechanisms shift the 
haemostatic balance to favour the activation of coagulation and, in the extremes, 
either disseminated intravascular coagulation or thrombosis. Inflammatory mediators 
can elevate platelet count, platelet reactivity, downregulate natural anticoagulant 
mechanisms, initiate the coagulation system, facilitate propagation of the coagulant 
response and impair fibrinolysis. Similarly, clotting can increase the inflammatory 
response both by releasing mediators from platelets and by activating cells, thereby 
promoting cell–cell interactions that increase the inflammatory responses [10, 11]. 
It is now well established that in sepsis, systemic inflammation invariably leads to 
activation of the coagulation system and inhibition of anticoagulant mechanisms and 
fibrinolysis. Activation of coagulation and subsequent fibrin deposition are essential 
parts of the host defense against infectious agents in an attempt to contain the 
invading microorganisms and the subsequent inflammatory response [12]. An 
exaggerated response, however, can lead to a situation in which coagulation itself 
contributes to disease in its most severe form causing microvascular thrombosis and 
organ dysfunction, a syndrome known as disseminated intravascular coagulation 
(DIC) [13]. It is becoming increasingly clear, that vice versa, components of the 
coagulation system are able to markedly modulate the inflammatory response [10, 
11]. 
 
5.2. The protein C pathway 
 
There are three major anticoagulant mechanisms that control the blood clotting 
process: tissue factor pathway inhibitor (TFPI), the heparin-antithrombin pathway and 
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the protein C (PC) anticoagulant pathway. During inflammation-induced activation of 
coagulation, the function of all 3 pathways can be impaired. There is a differential 
pattern of expression of the various anticoagulant pathways in different vascular 
beds; for example, in the coronary circulation, TFPI is mostly expressed in 
microvessels, whereas the protein C system is more universally present.  
The protein C system exerts its anticoagulant effect by regulating the activity of FVIIIa 
and FVa, the cofactors in the tenase and prothrombinase complexes, respectively. 
Protein C is a vitamin K-dependent multi-domain protein composed of a light and a 
heavy chain, the two chains being disulfide-linked. A vitamin K-dependent domain 
containing c-carboxy-glutamic acid (Gla) residues and two epidermal growth factor 
(EGF)-like domains occupy the light chain. The heavy chain contains a short 
activation peptide and a serine protease domain [14]. Vitamin K-dependent post-
translational carboxylation of glutamic acid residues generates the Gla residues. 
These residues are important for calcium binding to the Gla-domain and for the 
proper folding of the domain. The correctly folded Gla-domain binds negatively 
charged phospholipid membranes [15]. Protein C circulates as a proenzyme to an 
anticoagulant serine protease and is activated by thrombin bound to the endothelial 
membrane protein thrombomodulin (TM). Activated protein C (APC) cleaves and 
inhibits coagulation cofactors FVIIIa and FVa, which result in downregulation of the 
activity of the coagulation system [8]. The protein C pathway comprises multiple 
proteins involved in the different reactions. Thus, there are proteins affecting the 
activation of protein C by the Thrombin–TM complex, cofactor proteins that modulate 
the proteolytic activity of APC and serine protease inhibitors that inactivate APC. The 
endothelial protein C receptor (EPCR) stimulates the Thrombin–TM-mediated 
activation of protein C on the endothelial cell surface [16]. The two cofactors, protein 
S and the intact form of FV, enhance the anticoagulant activity of APC. Protein S is 
sufficient for inactivation of FVa, whereas regulation of FVIIIa in the tenase complex 
requires the synergistic contribution of protein S and FV. Protein S is a vitamin K-
dependent plasma protein, which in human plasma to 60–70% is bound to the 
complement regulator C4b-binding protein (C4BP). The free form of protein S 
function as APC cofactor, whereas the complexed form does not [17]. Protease 
inhibitors such as the protein C inhibitor (PCI), a1-antitrypsin, and a2-macroglobulin 
inhibit APC in plasma. The inhibition is relatively slow and the half-life of APC in 
circulation is approximately 20 min [18]. Recently, protein C has been shown not only 
 12
  
to express anticoagulant activities but also to function as an anti-inflammatory and 
anti-apoptotic factor. Moreover, APC has been found to be useful as a therapeutic 
agent in the treatment of sepsis with the unique combination of anticoagulant, anti-
inflammatory and anti-apoptotic properties of APC presumably being important [19]. 
 
5.2.1. Anticoagulant and profibrinolytic functions of APC 
 
APC, a plasma serine protease, is best known for its ability to inhibit blood clot 
formation [8, 20]. APC acts as an anticoagulant by degrading clotting factors Va and 
VIIIa, thereby attenuating the coagulation cascade. In vivo, APC is generated in the 
circulation “on demand” from its inactive precursor PC. The protease that triggers the 
conversion of PC to APC is thrombin. Briefly, vascular injury or inflammatory 
cytokines/endotoxin initiate the coagulation cascade, ultimately resulting in thrombin 
generation and blood clot formation. Excess thrombin then complexes with TM, a 
receptor on endothelial cells. The thrombin-TM complex rapidly converts PC to its 
active form APC. An accessory factor, EPCR, binds circulating PC and presents it to 
the thrombin-TM complex, which augments APC generation by 10– to 20-fold. 
Recently, the anticoagulant activities of APC have been shown to extend beyond its 
ability to degrade factors Va and VIIIa. It has been shown that APC inhibits TF 
expression and activity on U937 cells and on blood monocytes [21, 22]. 
 
Figure 1. Proposed actions of Activated protein C in modulating the systemic inflammatory, 
procoagulant, and fibrinolytic host responses to infection. Adapted from [23]. 
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In human blood monocytes challenged with LPS, recombinant human activated 
protein C (rAPC) inhibits TF antigen expression levels and TF procoagulant activity 
[21]. In human U937 monoblastic promyeloid leukemia cells, APC inhibits TF 
expression in phorbol ester stimulated cells in an EPCR-dependent manner [22]. 
These studies suggest that part of the protective effect of rAPC therapy may reflect 
the ability of rAPC to dampen the procoagulant potential of activated monocytes. 
APC also plays an important role as a profibrinolytic agent. Patients with severe 
sepsis have significantly increased levels of plasminogen activator inhibitor (PAI)-1, 
which has demonstrated to be predictive of poor prognosis [24]. APC neutralizes PAI-
1 activity thereby preventing the inhibition of tissue plasminogen activator (tPa) by 
PAI-1 and promoting clot lysis. Furthermore, the inhibition of thrombin generation by 
APC limits the activation of thrombin-activatable fibrinolysis inhibitor (TAFI) and 
diminishes the inhibition of fibrinolytic pathways [25]. 
 
5.2.2. Anti-inflammatory action of APC 
 
APC exerts direct anti-inflammatory effects on several cell types important in sepsis 
pathophysiology. In endothelial cells, APC modulates the p50/p52 subunits of the 
nuclear factor κB (NFκB) transcription factor complex and reduces the binding of the 
p65 subunit to DNA [26]. APC suppresses expression of endothelial cell adhesion 
molecules such as vascular adhesion molecule (VCAM)-1, inter-cellular adhesion 
molecule (ICAM)1, and E-selectin in TNF- stimulated cells [26]. Downregulation of 
endothelial cell adhesion molecules by APC reduces E-selectin-dependent rolling of 
leukocytes, thereby limiting diapedesis. APC also upregulates IL-6 and IL-8 in 
endothelial cells, which is hypothesized to attenuate the inflammatory response via 
inhibition of neutrophil migration and accumulation. Induction of monocyte 
chemoattractant protein (MCP)-1 in endothelial cells by APC may facilitate 
endothelial cell migration and proliferation, thereby accelerating wound healing [27]. 
Furthermore, APC upregulates endothelial cyclooxygenase (COX)-2 protein and 
mRNA expression in an EPCR and protease activated receptor (PAR)- 1-dependent 
manner. The upregulation of COX-2 levels by APC and release of prostacyclin (PGI2) 
may provide further benefit in sepsis by improving blood flow [28]. In blood 
monocytes and in the monocytic cell line THP-1, APC inhibits LPS-induced activation 
of NFκB resulting in the downregulation of pro-inflammatory cytokines [29, 30]. In 
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addition, rAPC inhibits the release of macrophage inflammatory protein-1-alpha (MIP-
1-α) from THP-1 cells [31]  and inhibits NFκB activation and MIP-1-α production from 
monocytes from septic patients [32]. Furthermore, rAPC upregulates the anti-
inflammatory cytokine IL-10 in blood monocytes, which might shift the balance of 
cytokines to promote anti-inflammatory effects [21]. APC may also exert anti-
inflammatory effects through inhibition of leukocyte chemotaxis [33-35]. In 
neutrophils, both PC and APC inhibit chemotaxis induced by IL-8, antithrombin, 
formyl-Met-Leu-Phe, or C5a [33]. In lymphocytes, PC and APC inhibit cell migration, 
an effect independent of direct PAR-1 or PAR-2 involvement [34]. Interestingly, in the 
studies mentioned, PC and APC were equally effective in inhibiting chemotaxis, and 
the effects were EPCR-dependent. In-vivo data further supports the anti-inflammatory 
properties of APC. In baboons infused with lethal doses of E. coli, exogenously 
added APC reduces coagulopathy and organ dysfunction, while inhibition of 
generated APC results in elevated levels of inflammatory cytokines [36]. Likewise, 
the PROWESS trial revealed that rAPC infusion reduced levels of IL-6 [23]. Studies 
in an endotoxemia rat model found that rAPC treatment attenuated the adherence of 
leukocytes to the endothelium in the intestinal wall and improved microvascular 
perfusion [37]. In a human model of endotoxin-induced pulmonary inflammation, 
rAPC treatment reduced neutrophil accumulation in the pulmonary airspace and 
prevented neutrophil chemotaxis as compared to placebo following endotoxin 
administration [38]. A recent study showed that APC and IL10 act as anti-
inflammatory agents by interfering with Wnt5A signaling and the general 
inflammatory response of human macrophages to LPS and INF [39]. 
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5.3. The Wnt pathway 
 
The Wnts comprise a large family of highly  conserved growth factors that are 
responsible for important developmental and homeostatic processes throughout the 
animal kingdom [40]. Their implication in a wide array of developmental events and 
human diseases has made Wnts and their signaling pathways the subject of intense 
investigation over the last two decades [41-43]. Membership in the Wnt family is 
defined by amino acid code sequence rather than functional properties. The 
mammalian genome encodes 19 Wnt proteins and 10 Frizzled (Fz) seven-pass 
transmembrane receptors, which suggests that, in theory, 190 potential Wnt-Frizzled 
combinations exist. It has been proposed that Wnts activate a number of different 
signaling pathways [44], each of which has been shown to intersect with numerous 
other intracellular signal transduction pathways. That activation of some, but not all, 
Wnt pathways requires co-receptors such as low-density lipoprotein receptor–related 
protein 5 (LRP5) and LRP6 further complicates matters. It now appears that LRP5/6 
has a second function: it binds to a molecule that counteracts Wnt [45]. That 
molecule is called Dickkopf (Dkk), meaning ‘fat head’, because it has the remarkable 
activity of promoting head formation in vertebrates [46]. Dkk and Wnt do not have 
similar amino-acid sequences, suggesting that Dkk does not act as a competitive 
inhibitor by binding to Frizzled or LRP5/6 in Wnt’s place. In fact, it does not bind to 
Wnt or to Frizzled at all. Mao et al.[45] found that DKK binds to LRP5/ 6 through a 
part of that is not needed for interactions with either Wnt or Frizzled. While Dkk1 acts 
as a pure inhibitor of Wnt/-catenin signaling, Dkk2 can either activate or inhibit the 
canonical pathway, depending on cellular context [47]. At low and high LRP5/6 levels 
Dkk2 functions as a Wnt inhibitor or activator, respectively. The ability of Dkk2 to act 
either as agonist or antagonist of Wnt/LRP6 signaling can also be regulated by the 
Dkk receptor Kremen 2 (Krm2), which invariability turns Dkk2 into a Wnt inhibitor [48]. 
Although the majority of work in the field to date has focused on -catenin-
dependent, or canonical, Wnt signaling, examples continue to accumulate in which 
Wnts and/or other key components of the canonical signaling cascade participate in 
-catenin-independent processes. 
 
 
 
 16
  
5.3.1 Wnt signaling through -catenin 
The defining event in canonical Wnt signaling is the cytoplasmatic accumulation of -
catenin and its subsequent nuclear translocation and activity. 
 
 
Figure 2. An overview of canonical Wnt signaling. A, in cells not exposed to Wnt, -catenin associates 
with and is phosphorylated by the destruction complex composed of Axin, APC, and GSK-3. 
Phosphorylated -catenin is then targeted for degradation. At the same time, Wnt target genes are 
repressed by the association of TCF with Groucho. B, Wnt binding to the Frizzled and LRP receptors 
induces phosphorylation of LRP and recruitment of Axin. Dsh is also phosphorylated, and the 
Axin.APC.GSK-3 complex is inhibited, leading to accumulation of cytosolic -catenin. Accumulated -
catenin then translocates to the nucleus, replaces Groucho from TCF, and activates target genes. 
Adapted from [49] 
 
Under unstimulated conditions, a -catenin destruction complex  formed by proteins 
that include Axin, adenomatous polyposis coli (APC), and glycogen synthase kinase 
3b (GSK-3) keeps cytoplasmatic levels of -catenin low through phosphorylation by 
GSK-3. Phosphorylated -catenin becomes ubiquitylated and is targeted for 
degradation by the proteasome [50]. Following Wnt binding to a receptor complex 
composed of members of the Frizzled (Fz) family of seven transmembrane, 
serpentine receptors and low density lipoprotein receptor-related protein (LRP), the 
Axin.APC.GSK-3 complex is inhibited, leading to a block in -catenin phosphorylation 
by GSK-3. Hypophosphorylated -catenin accumulates in the cytoplasm and is 
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translocated to the nucleus where it regulates target gene expression through 
partnerships with T cell specific transcription factor/lymphoid enhancer-binding factor 
1 (TCF/LEF) family of transcription factors resulting in changes in gene transcription 
[51]. Remarkable progress has been made on this pathway, which has revealed the 
importance of Wnt–β-catenin signaling not only in metazoan development, but also in 
degenerative diseases and cancer. Whereas extensive study of Wnt–β-catenin 
signaling has resulted in its understanding in great (though incomplete) detail, 
noncanonical Wnt signaling has remained less well defined, with multiple β-catenin–
independent pathways potentially existing side by side.  
5.3.2 -catenin independent Wnt signaling 
 
The best-understood variant Wnt pathway was first described in Drosophila, where it 
was shown to be instrumental for the establishment of planar cell polarity (PCP), a 
process in which fields of cells orient themselves relative to the plane of the tissue in 
which they reside. However, whereas there are clear roles for frizzled (which was 
discovered because of its polarity phenotype) and dishevelled in this pathway, 
neither LRP, β-catenin, nor TCF are involved [52, 53]. 
Experiments performed largely in Xenopus and zebrafish embryonic systems have 
suggested the existence of a "Wnt-Ca2+" signaling pathway [54, 55], in which the 
binding of Wnt promotes Frizzled-mediated activation of pertussis toxin-sensitive 
heterotrimeric guanine nucleotide–binding proteins (G proteins) [56]. This, in turn, 
stimulates the release of Ca2+ from intracellular stores, which leads to the activation 
of Ca2+-dependent effector molecules. Several Ca2+-sensitive targets - protein 
kinase C (PKC), Ca2+-calmodulin–dependent protein kinase II (CamKII), and the 
Ca2+-calmodulin- sensitive protein phosphatase calcineurin - have been identified 
downstream of the Wnt-Ca2+ pathway in vertebrates [55]. Targets of the Wnt-Ca2+ 
pathway appear to cross-talk to the Wnt–-catenin pathway at multiple points [57].  
Because Wnts can interact with more than one Frizzled, detailed analysis of 
individual Frizzleds may yield new insights into Frizzled-specific pathways of 
signaling and gene expression. The role of low-density lipoprotein receptor–related 
proteins 5 and 6 (LRP5 and LRP6) as coreceptors with Frizzled in the Wnt– -catenin 
pathway raises the question of a possible similar role for LRP proteins in Wnt-Ca2+ 
signaling.  
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5.3.3. Role of Wnt pathway in regulation of inflammation 
 
Genomic studies have detected upregulation of Wnt5a in macrophages and dendritic 
cells exposed to pathogens [58, 59] and during differentiation of monocytes into 
dendritic cells after exposure to GM-colony stimulating factor (CSF) and interleukin-4 
[60]. Together, this suggests that Wnt5a expression contributes to innate and 
adaptive immune responses. Support of this, upregulation of Wnt5a has been 
observed in pathological conditions involving inflammation such as rheumatoid 
arthritis [61] and in tumor associated macrophages [62]. One of the first direct 
indicators for the involvement of the Wnt pathway in inflammation and immunity was 
obtained from a study in Drosophila. Gordon and colleagues illustrated that the 
Drosophila Wnt protein family member WntD is upregulated in the fly via Toll/NF-B 
signaling and is involved in the innate immune system [63]. A subsequent study in 
human mononuclear cells demonstrated upregulation of Wnt5a in response to 
microbial stimulation required Toll/NF-B activation, indicating a similar mechanism in 
man [64]. Interestingly, this study also demonstrated that Wnt5a upregulates the 
microbially-induced IL-12 response of antigen-presenting cells and IFN- production 
by mycobacterial antigen-stimulated T-cells, illustrating a functional involvement in 
the antimicrobial defense. This was the first implication of the involvement of Wnt 
signaling in bridging innate and adaptive immunity to infections. In a recent  study 
utilizing an in vitro model of inflammatory macrophage activation, additional support 
for a role of Wnt5a in sustained macrophage activation is provided [39]. Macrophages 
stimulated with interferon (INF)- and endotoxin (LPS) consistently upregulated 
Wnt5a via Toll-like receptor activation. Wnt5a in turn upregulated expression of the 
proinflammatory genes, IL-6, IL-1, IL-8, and macrophage inflammatory protein-1 
(MIP-1). Attenuation of these effects by APC and the anti-inflammatory cytokine IL-
10 imply an active role of Wnt5a in the inflammatory response. This study is the first 
to provide a direct demonstration of relevance to pathological inflammation by 
showing higher levels of Wnt5a in patients with severe sepsis than healthy subjects. 
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Figure 3.  Working hypothesis of the role of Wnt5a in the inflammatory response. Activation of Toll-like 
receptors in macrophages by pathogens leads to activation of nuclear factor-B (NF-B) and 
upregulation of Wnt5a and cytokines. Increased levels of Wnt5a activate the noncanonical pathway 
via calcium/calmodulin dependent kinase II (CamKII) which results in sustained upregulation of 
inflammatory cytokines including IL12, IL6, IL8, IL1, and macrophage inflammatory protein 1 (MIP-
1) either in a nuclear factor of activated T-cells (NFAT)-dependent or independent manner. 
Aditionally, increased levels of Wnt5a and cytokines may affect other mononuclear cells including T-
cells and surrounding resident tissue cells. Adapted from [65]. 
 
 
5.4.Outline of the project 
 
Macrophages play a central role in inflammation by responding to and releasing of 
numerous inflammatory cytokines and chemokines, leading to severe systemic 
inflammation and septic shock. However, the knowledge of anti-inflammatory 
interactions on the level of monocytes/macrophages is still scant. Therefore, it was 
the aim of this thesis to:  
1. Define the transcriptional response of monocytes/macrophages to in vitro 
inflammation (LPS/INF). 
2.  Define new targets for the anti-inflammatory action of APC. 
3.  Elucidate the role of the Wnt pathway in inflammation. 
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ABSTRACT 
 
 
Activated protein C (APC) has been introduced as a therapeutic agent for treatment 
of patients with severe sepsis due to its unique anticoagulant and anti-inflammatory 
properties. In this study we investigated novel targets for the anti-inflammatory action 
of APC in inflamed macrophages.  
Using a genome-wide approach, we profiled gene expression in human 
macrophages exposed to lipopolysaccharide (LPS) and interferon (IFN)-γ in the 
presence or absence of APC and identified for the first time genes regulated by APC 
under inflammatory conditions, such as chromatin binding protein 4B (CHMP4B), and 
p300/CBP-associated factor (PCAF), indicating a role of APC in epigenetic control of 
gene transcription. A functional assay showed the influence of APC in the 
acetyltransferase/deacetylase activity of nuclear extracts from inflamed 
macrophages.  
Our data sheds new light on APC targets in inflammation and opens lines of 
investigation to be explored in order to further elucidate its unique molecule 
properties. 
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INTRODUCTION 
 
The process of inflammation in response to injury or infection, a crucial part of the 
innate immunity, is characterised by activation, adhesion and transmigration of 
leukocytes through the vascular endothelium to the site of inflammation with the aim 
to locally repel microbial invasion and repair damaged tissues. In inflammation, 
immunovascular communication of circulating cells and vascular endothelium is 
mediated by production of pro-inflammatory factors such oxidation products, nitric 
oxide, inflammatory cytokines and chemokines, and the expression of adhesion 
molecules [1]. Although local inflammatory processes as defense mechanism are 
necessarily transient in nature, requiring a rapid induction and rapid termination, in 
severe infection they have significant potential to spread from the local site to non-
affected tissues and elicit a systemic inflammatory response. Thus, severe systemic 
inflammatory response proceeds to a generalised intravascular inflammation with 
shock, organ dysfunction and high mortality [2]. Monocytes are an essential part of 
the innate immunity. They can differentiate into macrophages and dendritic cells and 
are crucial for the initiation of an adaptive immune response, clearance of infectious 
agents as well as resolution of inflammation. Inflammation due to tissue damage or 
infection results in macrophage activation, which increases the production of 
cytokines, chemokines, and other inflammatory mediators. The classical activation of 
macrophages is achieved by stimulation with interferon (INF) followed by exposure 
to a microbial trigger like lipopolysaccharide (LPS) resulting in a pro-inflammatory 
phenotype [1, 3]. By release of an array of pro-inflammatory mediators that 
communicate with cells of the vasculature they play a key role in the onset of 
systemic inflammatory responses. Because of the redundancy of inflammatory 
mediators involved, therapeutic intervention in severe systemic inflammatory 
response syndrome is challenging. Targeting the major inflammatory cytokines IL-1 
or TNF-α, and lipopolysaccharide (LPS) was unsuccessful in treatment of sepsis. 
Furthermore, during severe systemic inflammation disseminated intravascular 
coagulation occurs because of the pro-adhesive endothelial environment and tissue 
factor expression on monocytes with consecutive intravascular thrombin formation [3, 
4]. Activated protein C (APC), a plasma serine protease, is best known for its ability 
to control thrombin formation. APC acts as an anticoagulant by inhibiting activated 
clotting factors such as FVa and FVIIIa, thereby attenuating thrombin formation. In 
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addition to its anticoagulant properties, APC has been shown to modulate cell 
functions including inflammation, apoptosis, and vascular permeability [5]. In a 
previous study we found that APC affected the pro-adhesive endothelial environment 
by downregulating the induction of endothelial adhesion molecules and monocyte 
chemotactic protein-1 [6]. Recently, recombinant human APC has been introduced as 
a therapeutic agent for treatment of patients with severe sepsis due to its unique 
anticoagulant and anti-inflammatory properties [7]. However, the exact mechanism of 
the anti-inflammatory action of APC, in particular on inflammatory activated 
monocytes, is not fully understood.  
Genome-wide approaches provide the ability to survey the expression level of 
thousands of genes simultaneously and are a powerful tools for exploring complex 
interactive networks of genes and signaling pathways. Because monocytes constitute 
an important cellular compartment involved in severe systemic inflammatory 
responses and to characterize novel targets for the anti-inflammatory action of the 
physiologic anticoagulant APC in this cellular system, we undertook expanded gene 
expression analysis of the whole human transcriptome. 
In our present study we used a highly standardised setting of primary human 
monocytes activated with LPS and IFNγ and whole genome oligonucleotide arrays to 
define the complete transcriptome of blood monocytes in response to inflammatory 
activation. Moreover, we defined for the first time the gene expression profile of the 
effect of APC in inflammatory activated blood monocytes. Thereby we identified as 
targets of APC signalling molecules and transcription factors not known to be 
expressed in monocytes or assigned to inflammatory responses so far.  
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MATERIALS AND METHODS 
 
Cell culture 
Human macrophages were prepared from buffy coats of healthy blood donors (blood 
donation program; Swiss Red Cross, Zurich, Switzerland), by a strictly standardised 
protocol. Briefly, after separation by Ficoll gradient (Ficoll-paqueTM Plus, Amersham 
Biosciences, Amersham Basel, Switzerland) and three washes with Mg/Ca-free 
phosphate-buffered saline (PBS, Gibco Europe, Basel, Switzerland), cells were 
suspended in Iscove’s modified Dulbecco’s medium (IMDM; Invitrogen) 
supplemented with 10% heat-inactivated pooled human serum (human serum Off 
The Clott, PAA, Austria) and seeded at a density of 1 X 107 cells/mL in 6-well tissue 
culture plates (Falcon Oxnard, USA). Purified monocytes were obtained after 2h 
incubation under cell culture conditions in a SteriCult tissue culture incubator (Forma 
Scientific, Waltham, Massachusetts, USA) and four times washing in warmed Gey’s 
balanced salt solution at a purity of > 98% as determined by Giemsa staining. After 
24h, medium was replaced by IMDM supplemented with 2% human pooled serum. 
Cells were stimulated for 8h with human recombinant IFN- (100u/mL), IL-10 (5 
ng/mL, both from PrepoTech, Rocky Hill, USA), lipopolysaccharide (LPS 10ng/mL, 
from Escherichia coli 055:B5, Difco Laboratories, Detroit, MI, USA), human 
recombinant activated protein C (rhAPC, XigrisTM, Lilly, Switzerland). 
 
DNA microarray hybridization and analysis  
Differential gene expression profiling of human macrophages was performed as 
described previously [8]. 
 
Functional clustering 
To analyze the microarray data in the context of biological functions we used 
information available from the Gene Ontology (GO) consortium 
(http://www.geneontology.org). The GO terms represent a defined vocabulary 
describing the biological process, cellular components, and molecular functions of 
genes in a hierarchical acyclic graph structure. Statistical analysis was performed 
using GeneGO software. For each of the existing GO terms, the cumulative number 
of genes meeting our criteria (e.g. up- or downregulated) and of all genes 
represented in the microarray was calculated. The Z score is calculated for every GO 
term as described [9]. A positive Z score indicates that there are more genes meeting 
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the criterion in the specific GO term than expected by chance. The Z score is 
transferred to p-values under the assumption of a hypergeometric distribution. 
 
RNA isolation and quantitative real-time reverse transcription PCR (RT-PCR) 
Total cellular RNA was isolated using the Qiagen RNeasy Mini Kit (Qiagen, Basel, 
Switzerland), which included a DNase digest. Total RNA was quantified 
spectrophotometrically and equal amounts (5 μg) were transcribed into cDNA with 
oligo(d)T primers and StrataScript RT Reverse Transcriptase using the StrataScript 
First-Strand Synthesis System (Stratagene, Rotkreuz, Switzerland). Duplicates of 
cDNA were amplified by RT-PCR with gene-specific primers using the 7500 Fast 
Real-Time PCR system (Applied Biosystems Inc., Rotkreuz, Switzerland) and the 
Power SYBR Green Master Mix (Applied Biosystems). Sequence-specific primers 
were selected using Primer Express v2.0 software (Applied Biosystems). The 
following primers were employed for Wnt5A and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH): GAPDH forward, 5'-AAC AGC GAC ACC CAC TCC TC-3'; 
GAPDH reverse, 5'-GGA GGG GAG ATT CAG TGT GGT-3'. Primers for cytokines 
were as follows: IL1β-forward, 5’-CAG AAA ACA TGC CCG T-3’, IL1β reverse, 
5’GCA CTA CCC TAA GGC AG-3’, IL8 forward, 5’-AGA CAG CAG AGC ACA CAA 
GC-3, IL8 reverse, 5’-ATG GTT CCT TCC GGT GGT-3’, MCP-1 forward, 5’-CCC 
CAG TCA CCT GCT GTT AT-3’, MCP-1 reverse, 5’-AGA TCT CCT TGG CCA CAA 
TG-3’, MIP1b forward, 5’-GAA AAC CTC TTT GCC ACC AA-3’, MIP1b reverse, 5’-
TCA CTG GGA TCA GCA CAG AC-3’, HOXC10 forward, 5’-GAC CTG TGG TTC 
GTG C-3’, HOXC10 reverse, 5’-GCG GAT GGA TTC GAT CT-3’, TIGD4 forward, 5’-
AGC AAC GAA GAG TGG T-3’, TIGD4 reverse, 5’-CTC TGG GGT TAC AGC C-3’, 
PCAF forward, 5’-GCA AGT CAA GGG CTA TGG-3’, PCAF reverse, 5’-GTG TAC 
GGG ATC CGT G-3’, CHMP4B forward, 5’-ACT TGT ACG GTA CTG GC-3’, 
CHMP4B reverse, 5’-TCG AGA TAT TTA ATA GAC AGT GC-3’, SOCS7 forward, 5’-
CCG AAA GTT CTA CTA CTA TGA T-3’and SOCS7 reverse, 5’-AGA GTA CGG 
TCA TGT GC-3’. PCR was carried out with an initial denaturation step (10 min, 95°C) 
followed by 40 cycles of denaturation (15 sec, 95°C), annealing (30 sec, 55°C), and 
extension (30 sec, 72°C). Fluorescence was measured at the end of each extension. 
Relative mRNA levels were quantified by RQ Study SDS Software v1.3.1 (Applied 
Biosystems) using the comparative Ct method. The expression level of each gene 
was normalized to GAPDH levels in each experimental sample. Final data were 
 31
  
expressed as mRNA expression in treated cells relative to expression in untreated 
cells. A melting curve analysis was performed for each amplicon to verify the 
specificity of each amplification step. 
 
Western blotting 
For assaying HOXC10 and SOCS7 protein expression, cells were lysed with 
Mammalian Cell Lysis/Extraction reagent (Sigma-Aldrich Chemical Co., Buchs, 
Switzerland) supplemented with complete mini protease inhibitor cocktail tablets 
(Roche Diagnostics Schweiz AG, Rotkreuz, Switzerland). After clearing the lysates 
by high-speed centrifugation, protein concentrations of each sample were determined 
using a Protein Bradford assay (Bio-Rad Laboratories AG, Reinach, Switzerland). For 
immunoblotting, 20μg total protein of each sample was resolved on SDS 4–15% 
gradient polyacrylamide gels and transferred to PVDF membrane (Millipore AG, Zug, 
Switzerland). After transfer, the membranes were incubated for 1h in blocking 
solution (5% non-fat milk in PBS containing 0.1% Tween-20) and then 1h with mouse 
anti-HOXC10 (1:1000. abnova) or rabbit anti-SOCS7 (1:1000, abcam) in blocking 
solution. Antibody binding was detected with a horseradish peroxidase-coupled 
sheep-anti rabbit or donkey-anti rabbit secondary antibody diluted 1:10’000 followed 
by enhanced chemiluminescence (ECL) detection (ECL Plus, Amersham Pharmacia 
Biotech, Inc., Uppsala, Sweden). 
 
Measurement of cytokine production 
The inflammatory cytokines IL-8, IL-1, MIP-1 and MCP-1 were measured in 
undiluted monocyte supernatants using a multiplex assay on the BioPlex 2200 
platform (Bio-Rad, Hercules, CA, USA), with commercial antibody-coated beads, 
standards, and reagents, according to the manufacturer’s instructions (Bioplex 
human cytokine multiplex assay system, BioRad). Complete medium was used as 
blank. Data were analyzed on the Bioplex Reader using the BioPlex 3.0 software 
(Bio-Rad). 
 
Histone acetyltransferase (HAT)  activity 
HAT activity of nuclear extracts was measured with a colorimetric assay that 
measures NADH produced upon acetylation of a peptide substrate, following 
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manufacturer recommendations (HAT Activity Colorimetric Assay Kit, BioVision, 
California, USA). 
 
Histone deacetylase (HDAC) activity 
HDAC activity of nuclear extracts was measured with a colorimetric assay, following 
manufacturer recommendations (Colorimetric HDAC Activity Assay Kit, BioVision, 
California, USA). 
 
 
RESULTS 
 
Differential gene expression of inflamed human monocytes  
Human monocytes prepared from buffy coats of healthy blood donors were cultured 
for 24h and then stimulated with INF- and LPS. Unstimulated monocytes were used 
as the baseline control. The transcriptional profiles were then determined by 
microarray analysis using Agilent human 44k 60-mer oligonucleotide microarray 
chips. Profiles of identical experimental settings from three independent donors were 
analysed with Rosetta biosoftware. After 8h stimulation, 2979 genes were regulated 
more than 2-fold (p<0.01) in these monocytes. Of the 2547 genes affected after 8h 
by INF/LPS stimulation, 1692 were upregulated, (with a maximal change of 222.5-
fold) and 1287 were downregulated (with a maximal change of 18.0-fold). The 
maximally regulated genes were ankyrin repeat domain 22 (ANKRD22, 222-fold 
increased expression) and selenoprotein P (SEPP1, 18-fold decreased expression). 
The majority of differentially expressed genes were identified as unique and named in 
GenBank, whereas the remaining transcripts were either identified as unnamed 
expressed sequence tags or were hypothetical. The complete set of genes regulated 
upon inflammatory activation 2-fold or higher is deposited in the ArrayExpress 
database, accession number E-MEXP-927. 
To determine which functional categories are overrepresented among regulated 
genes with a given statistical significance, we performed automated unbiased 
clustering using GeneGO software. Genes displaying at least 2.0-fold differential 
expression levels were classified into various categories based on the biological 
function(s) of the encoded protein to determine the global direction of the molecular 
response to inflammation (Figure 1). Classification according to GO biological 
processes revealed that most genes upregulated by LPS/INF fall into the functional 
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categories related to immune response and inflammatory response. In the 
downregulated genes, there was an overrepresentation of the protein kinase cascade  
and response to stress functional categories as well as an underrepresentation of 
categories related to metabolic processes. 
 
Effect of activated protein C on inflamed macrophages 
APC has been shown to down-regulate TNF production by monocytes and to inhibit 
the production of inflammatory cytokines and chemokines in LPS-stimulated THP-1 
cells [10, 11].   
To examine the effect of APC in our experimental setup, real-time PCR was used to 
verify the mRNA levels of IL-1  and IL-8 as well as MCP-1 and MIP-1 in all samples 
used for microarray experiments. As shown in Figure 2, APC downregulates the 
mRNA level of IL-1 , IL-8, MCP-1, and MIP-1 (Figure 2A) and the protein 
expression of MCP-1, and MIP-1 (Figure 2B) in monocytes stimulated with 
LPS/INFγ. 
In order to define unknown targets of APC on inflamed macrophages, we compared 
the mRNA expression profiles of macrophages incubated with LPS/INFγ with or 
without APC. Re-ratio analysis using Rosetta Biosoftware follwed by one-way 
ANOVA [8], revealed 570 genes differentially expressed by inflammatory activation 
and these were significantly (more than 2-fold change, p<0.05) up- or down-regulated 
by APC. Of the 570 genes affected by APC upon LPS/INFγ stimulation, 440 genes 
were upregulated (with a maximal change of 14.8-fold), and 130 genes were 
downregulated (with a maximal change of 26.4-fold). The maximally regulated genes 
were tigger transposable element derived 4 (TIGD4, 14.8-fold increased expression) 
and angiomotin like 1 (AMOTL1, 26.4-fold decreased expression).  
Among the genes downregulated by APC is Wnt5A, a gene that recently emerged to 
be an important factor for the Toll-mediated inflammatory signaling in macrophages. 
A detailed study of the anti-inflammatory impact of Wnt5A regulation by APC has 
recently been described [8]. 
To determine which functional clusters were overrepresented among APC regulated 
genes, we applied the same analysis (GeneGO software) as in the genes regulated 
by LPS/INF. Among the genes downregulated by APC, there was significant 
underrepresentation of genes involved in intracellular transport and protein transport 
and overrepresentation of genes involved in the adenylate inhibiting pathway and the 
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phospholipase C activating pathway. The genes upregulated by APC showed an 
overrepresentation of genes involved in the regulation of ATPase activity and an 
underrepresentation of genes involved in phosphoinositide metabolic process and 
negative regulation of protein amino acid phosphorylation. 
 
Confirmation of microarray results by RT-PCR and Western Blot. 
Using quantitative real-time RT-PCR we confirmed the expression patterns obtained 
by microarray analysis for selected genes related to regulation of gene transcription 
(TIGD4, HOXC10, CHMP4B and PCAF) and cytokine secretion (SOCS7) that have 
not been previously linked to the anti-inflammatory action of APC (Figure 4). The 
regulation was also confirmed at the protein level (HOXC10 and SOCS7). For the 
other gene transcripts (TIGD4, CHMP4B and PCAF) were no antibodies available. 
APC significantly upregulates TIGD4, PCAF and SOCS7 whereas HOXC10 and 
CHMP4B were significantly downregulated by APC. 
 
APC alters the balance between acetylase and deacetylase activity in inflamed 
macrophages. 
Transcription of eukaryotic genes is complex and depends on different coactivators, 
such as p300, PCAF and c-AMP response element-binding protein, as well as 
histone acetyltransferases (HATs) and histone deacetylases (HDACs). HATs are 
responsible mainly for destabilizing the chromatin structure to allow accessibility of 
different transcription factors. In contrast, HDACs serve as corepressors of gene 
transcription by restoring the condensation of DNA in chromatin. 
Because PCAF was one of the genes significantly regulated by APC upon 
inflammatory stimulus and it has acetyltransferase activity, we hypothesized that APC 
might regulate activity of HATs. As shown in Figure 5A, APC significantly 
downregulate histone acetyltransferase activity in nuclear extracts of inflamed 
monocytes after 8h but not after 45min exposure. This indicates that APC has a long-
term effect. As gene expression is regulated by a balance between HAT and HDACs, 
we also investigated APC effect on HDACs activity (Figure 5B) and found that APC 
inhibits HDAC activity in inflamed monocytes after 45min and 8h stimulation 
suggesting a fast and prolonged effect of APC on HDAC activity. 
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DISCUSSION 
 
Circulating monocytes play a major role in the immediate host response to invading 
microorganisms. The primary functions of monocytes include the phagocytosis of 
invading pathogens and the synthesis and secretion of proinflammatory cytokines, 
chemokines and growth factors. In this study, we determined the transcriptional 
changes occurring in human monocytes after inflammatory stimulation (LPS and 
INF). The genes mostly regulated by inflammatory stimuli were ankyrin repeat 
domain 22 (increased expression) and selenoprotein P (decreased expression). The 
ankyrin-repeat domain (ARD) was first discovered as a repeated sequence in yeast 
cell-cycle regulation proteins [12, 13]. It is named after ankyrin, a cytoskeletal adapter 
protein, which contains 24 tandem copies of the repeat [13]. Since first being 
discovered, over 2800 ankyrin repeat proteins have been identified, each containing 
between three and 24 copies of the ankyrin repeat [14, 15]. Ankyrin repeats are 
common in signaling proteins, and appear to be general protein–protein interaction 
motifs [15]. The upregulation of ankyrin repeat domain 22 under inflammatory 
conditions is novel and may represent an increase of several proteins containing this 
domain that are involved in the inflammatory response, such as IB [14]. 
Selenoprotein P is the major transporter of selenium, a trace element required for 
normal development [16]. The downregulation of selenoprotein P in our experimental 
setup is in line with previous findings that human and/or murine Sepp1 gene 
promoter activity is impaired by IFN- , TNF- , and IL-1β [17, 18] while induced by 
TGF-β [18] and IL-10 [19] suggesting a differential regulation of selenoprotein P 
expression during inflammatory reactions [14]. Functional clustering, of genes 
significantly regulated by inflammatory stimuli, showed a significant 
overrepresentation of genes involved in the inflammatory response (upregulated 
genes) and genes associated with lipid metabolic process (downregulated genes). 
The overrepresentation of downregulated genes associated with lipid metabolic 
process highlight the fact that macrophages are an active source of pro- and anti-
inflammatory lipid mediators. Modulation of genes involved in general cellular 
metabolic activities is a prominent feature of macrophage differentiation and 
polarization. Also, macrophages are a major component of adipose tissue and play a 
role in the metabolic syndrome [20]. 
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We and others have focused on the effects of activated protein C on monocytes, cells 
that play a critical role in initiating, perpetuating, and modulating the immediate host 
response to invading microorganisms. Activated protein C has been shown to exert 
direct anti-inflammatory effects on monocytes by inhibiting the production of 
proinflammatory cytokines [21, 22]. Using a genome wide approach we tried to 
identify novel targets for the anti-inflammatory action of APC. The genes most highly 
regulated by APC were TIGD4 (increased) and angiomotin like 1 (decreased).  
TIGD4 belongs to the tigger subfamily of the pogo superfamily of DNA-mediated 
transposons in humans [23]. These proteins are related to DNA transposons found in 
fungi and nematodes. They are also very similar to the major mammalian centromere 
protein B [23]. Other novel APC targets were chromatin binding protein 4B 
(CHMP4B), and p300/CBP-associated factor (PCAF), which may indicate a role of 
APC in epigenetic control of gene transcription. In fact, PCAF has histone 
acetyltransferase activity, and through an acetyltransferase activity assay we were 
able to show that APC inhibits histone acetyltransferase activity in nuclear extracts 
from inflamed monocytes (Figure 5A). In health, the expression of genes coding for 
many proinflammatory cytokines remains silent. Mechanisms of transcriptional 
repression dominate until overcome by stimulation from extracellular stress signals 
such as microbial products via the Toll-like receptors. Although several transcription 
factors initiate de novo expression of proinflammatory cytokines, synthesis and 
secretion are tightly controlled events. Therefore, any mechanism for cytokine 
production is a potential target for acetylation and histone acetyltransferase (HAT) 
and deacetylase (HDAC) activity regulation. Acetylation of transcription factors can 
alter interactions between transcription factors and DNA and among different 
transcription factors, and is an integral part of transcription and differentiation 
processes. HATs are responsible mainly for destabilizing the chromatin structure to 
allow accessibility of different transcription factors, including NF-kB to the 
transcriptional site in the DNA. NF-kB can induce histone acetylation and other 
histone modifications in a temporal manner [24] leading to recruitment of other co-
activator and remodelling complexes and the induction of inflammatory gene 
expression [25]. A recent study showed that HAT activity would be required to ensure 
the time-dependent induction of the inflammatory genes IL6, IL8 [26, 27], therefore 
an inhibition of HAT activity would contribute to the downregulation of these 
proinflammatory cytokines.  
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The inhibiton of HDAC activity by APC was unexpected, but several experimental 
studies have demonstrated that HDACs inhibitors can modulate immune responses 
[28-30]. Recent studies have shown that pretreatment with suberoylanilide 
hydroxamic acid (SAHA), an HDAC inhibitor significantly reduced LPS-induced 
secretion of TNF- by peritoneal macrophages [28] by impairing transcription factor 
recruitment [31]. Our results suggest that APC exerts its anti-inflammatory action by 
altering the acetylation balance in inflamed macrophages. 
Among the genes regulated by APC was also the homeobox domain C10 (HOXC10). 
HOXC10 is one of the highly conserved HOXC family members of transcription 
factors that play an important role in morphogenesis, cell differentiation, and 
proliferation [32-34]. The HOXC protein levels are controlled during cell differentiation 
and proliferation. Selected Hox proteins have been shown to directly and indirectly 
regulate the expression of many angiogenic and growth factors, including basic 
fibroblast growth factor, vascular endothelial growth factor, IL8, and Ang2 [34]. The 
functional role of HOXC10 in inflammation is a question that needs to be clarified in 
further studies.  
SOCS (suppressor of cytokine signaling) proteins are known to act as negative 
regulators of cytokine action via inhibition of JAK/STAT signaling [35]. The SOCS 
family consists of 8 proteins (cytokine-inducible SH2-containing protein CIS and 
SOCS1-SOCS7). There is very little known about the function of SOCS7. It has been 
shown to interact with vinexin [36]. As vinexin is involved in the signal transduction 
from EGF-R to JNK and in cytoskeletal organization and cell spreading, SOCS7 
could modulate these functions and thus play a role in adhesion-dependent signaling 
and in cytoskeletal remodeling in normal and transformed cells [37]. The observation 
that SOCS7 expression is induced by APC is novel and precise consequences 
resulting from this induction should be further elicidated.  
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FIGURE LEGENDS 
 
Figure 1 - Functional clustering of genes regulated by LPS/INF.  
The gene expression profile of monocytes treated with LPS/INF compared with 
untreated control was analyzed with Rosetta Biosoftware [8]. Genes showing at least 
a 2.0 fold change were selected and characterized according to their GO biological 
process in the GeneGO software and compared with the classification of all genes 
present in the array in order to find which functional categories were significantly 
(p<0.05) over- or underrepresented [9] in the genes downregulated (A) or 
upregulated (B) by LPS/INF. The blue bars represent the genes regulated by 
LPS/INF and the orange bars represent all genes represented in the microarray.  
 
Figure 2 – Regulation of inflammatory mediators by APC. 
(A) Fold induction of IL1β, IL8, MCP1 and MIP1 β mRNA expression in LPS/INFγ 
stimulated monocytes treated with and without APC for 8h. Changes in mRNA 
expression were normalized to changes in GAPDH expression and are expressed as 
mean  SD from at least three independent experiments. *p<0.05. 
(B) Concentrations of IL1β, IL8, MCP1 and MIP1 β secreted by macrophages. Cells 
were stimulated with LPS/INF in the absence or presence of APC. Control cells 
were untreated. Cytokines were measured in cell culture supernatants collected 12h 
after treatment using the Bio-Plex Human Cytokine Multiplex Assay on the Bio-Plex 
2200 platform. Cytokine concentrations in treated cells were normalized to the 
concentrations in control cells and are presented as mean  SEM from three 
independent experiments. *p<0.05. 
 
Figure 3 -Functional clustering of genes regulated by APC in inflamed macrophages.  
The gene expression profile of monocytes treated with LPS/INF vs LPS/INF/APC 
was analyzed with Rosetta Biosoftware. Genes showing at least a 2.0 fold change 
were selected and characterized according to their GO biological process in the 
GeneGO software and compared with the classification of all genes present in the 
array in order to find which functional categories were significantly (p<0.05) over or 
underrepresented in the genes downregulated (A) or upregulated (B) by APC. The 
blue bars represent the genes regulated by LPS/INF and the orange bars represent 
all genes present in the array. 
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Figure 4 – Statistical analysis of APC effect on inflamed monocytes gene expression. 
In a first step of data analysis, Fold changes (up or down regulated) of gene 
expression were calculated using the re-ratio function of Rosetta Biosoftware that 
allows direct comparison between two samples (LPS/INF and LPS/INF/APC) that 
were both hybridized against a common reference (untreated control). All sequences 
with a calculated fold change of more than 2.0 (p<0.01) were subjected to one-way 
anova factorial analysis, compared with the significantly regulated sequences (fold 
change >2, p value<0.01) by LPS/INF. The ANOVA plot displays each gene (dot) in 
relation to its p-value (y axe) and the ranked sequence number (x-axe). Effects are 
considered significant at a p-value <0.01. Significantly regulated genes are plotted 
bellow the dashed red line. Highlighted genes, represented in red, were confirmed by 
real-time PCR (bar graphs, data are represented as mean  SEM from three 
independent experiments. *p<0.05) and when possible (antibody availability) by 
Western Blot. 
 
Figure 5 – APC alters the histone acetyltransferase/deacetylase activity balance in 
inflamed monocytes. (A) Colorimetric determination of HAT activity in nuclear 
extracts of macrophages treated with LPS/INF with and without APC for 45min (left) 
or 8h (right). Data are represented as mean  SEM from three independent 
experiments. *p<0.05. (B) Colorimetric determination of HDAC activity in nuclear 
extracts of monocytes treated with LPS/INF with and without APC for 45min (left) or 
8h (right). Data are represented as mean  SEM from three independent 
experiments. *p<0.05. (C) Chemiluminescent determination of MEF2 activity in 
nuclear extracts of macrophages treated with LPS/INF with and without APC for 
45min. Data are represented as mean  SEM from three independent experiments. 
*p<0.05 
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ABSTRACT 
 
Objective-Sepsis is a major cause of death for intensive care patients. High 
concentrations of inflammatory cytokines are characteristic of severe systemic 
inflammation and activated monocytes are their predominant cellular source. To 
identify targets for anti-inflammatory intervention, we investigated the response of 
human macrophages to inflammatory and anti-inflammatory mediators. 
Methods and Results- We profiled gene expression in human macrophages 
exposed to lipopolysaccharide (LPS) and interferon (IFN)-γ in the presence or 
absence of recombinant activated protein C (APC) or interleukin (IL)-10 and identified 
Wnt5A as one of the transcripts most highly induced by LPS/IFN-γ and suppressed 
by APC and IL-10. We confirmed regulation of Wnt5A protein in macrophages and 
detected it in sera and bone marrow macrophages of patients with severe sepsis. We 
established that a functional Wnt5A/frizzled-5/CaMKII signaling pathway was 
essential for macrophage inflammatory activation. To prove the essential contribution 
of Wnt5A we measured inflammatory cytokines after stimulation with Wnt5A, silenced 
Wnt5A by siRNA, and blocked receptor binding with soluble Frizzled–related peptide-
1 (sFRP1).  
Conclusion- Wnt5A is critically involved in inflammatory macrophage signaling in 
sepsis and is a target for anti-inflammatory mediators like APC or antagonists like 
sFRP1. 
 
 
 
CONDENSED ABSTRACT 
Gene expression profiling in human macrophages exposed to lipopolysaccharide and 
interferon-γ in the presence or absence of recombinant activated protein C or 
interleukin-10 identified Wnt5A as one of the most prominently regulated  transcripts 
by these mediators. Wnt5A is critically involved in inflammatory macrophage 
signalling in sepsis.  
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INTRODUCTION 
Sepsis is a suspected or proven infection with a systemic inflammatory response. In 
severe sepsis, organ dysfunction also occurs and it is associated with a high mortality 
and morbidity. Severe sepsis still causes about 9.3% of all deaths in the USA1,2.  
During sepsis, the extent of plasma protein C depletion correlates with the severity of 
the outcome3. In animal studies4 and clinical trials activated protein C (APC) 
prevented death from severe sepsis or septic shock5. While this beneficial effect of 
APC is mostly ascribed to its anticoagulant properties, anti-inflammatory effects of 
APC have also been proposed6. The direct modulation of inflammation by APC has 
recently been described in gene expression profiling studies with human endothelial 
cells7,8. Recently, recombinant human APC has been introduced as a therapeutic 
agent for treatment of patients with severe sepsis due to its unique anticoagulant and 
anti-inflammatory properties; however, the exact mechanism of anti-inflammatory 
action is still unknown9. 
Macrophages play a central role in inflammation by responding to and releasing of 
numerous inflammatory cytokines and chemokines, leading to severe systemic 
inflammation and septic shock. However, the knowledge of anti-inflammatory 
interactions on the level of monocytes/macrophages is scant. Therefore, we decided 
to expand our investigations on anti-inflammatory effects of APC on this cellular 
system. In the present study, we were using a whole genome expression analysis 
approach, to define novel targets of APC in an in vitro model of inflammatory 
macrophage activation. Using probes obtained from human macrophages stimulated 
by interferon- (IFN-) and endotoxin (LPS), we consistently found Wnt5A to be one 
of the genes induced by inflammatory stimuli and LPS which was blocked by APC at 
the transcriptional level. 
Wnt5A is a member of the Wnt family of secreted signaling molecules, homologs of 
the Wingless proteins in Drosophila species10. Wnt proteins are involved in 
embryonic development, in differentiation of white blood cells during mammalian 
hematopoiesis, and in tumorigenesis11. The canonical Wnt signaling pathway 
controls target gene transcription via the central component β-catenin12. Recently, 
regulation of β-catenin dependent gene transcription has been elucidated13, and in 
mammalian cell systems it predominantly involves Wnt311. However, in our pro-
inflammatory activated human macrophage cellular system, Wnt3 expression was 
extremely low (see supplemental material, Table II, available online at 
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http://atvb.ahajournals.org) and the canonical signaling pathway was not affected by 
either pro-inflammatory activation or by APC and IL-10. Recently, a member of the 
Drosophila Wnt protein family, WntD, has been linked to Toll/NF-κB signaling and 
shown to be involved in antibacterial defence against Listeria monocytogenes in a 
septic fly model14. Furthermore, in a recent study Wnt5A and its receptor Frizzled-5 
(FZD5) are involved in regulation of the response to microbial stimulation in human 
mononuclear phagocytes15. 
Here we show that Wnt5A acts through Ca2+/calmodulin dependent protein kinase 
(CaMKII) and that this pathway contributes to the inflammatory response of human 
macrophages. APC and IL-10 modulate Wnt5A/CaMKII signaling in an anti-
inflammatory manner. The presence of high levels of Wnt5A in sera of patients with 
severe sepsis or septic shock and in activated macrophages from the bone marrow 
of septic shock patients suggests a critical role for Wnt5A in systemic inflammation 
and sepsis. Taken together, our study shows for the first time that, first, Wnt5A 
signaling is essential to the general inflammatory response of human macrophages 
and, second, APC acts anti-inflammatory in activated human macrophages by 
interfering with Wnt5A signaling. 
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METHODS 
Cell Culture 
Human PBMC derived macrophages were cultured as described in the supplement 
(available online at http://atvb.ahajournals.org). 
 
Gene Array Experiments 
Gene expression profiling was performed by competitive dual-color hybridization of 
complementary RNA probes on human 44K 60-meroligonucleotide microarray chips 
(Agilent Technologies, Palo Alto, CA, USA) as described in the supplement. 
 
Quantitative Real Time RT-PCR 
Real-Time PCR is described in the supplement. 
 
Antibodies 
The following antibodies were used for western blotting and immunofluorescence: 
goat-anti-Wnt5A (1:1000, R&D Systems, Minneapolis, USA), rabbit-anti-FZD5 
(1:1000, Abcam, Cambridge, UK), rabbit-anti-CaMKII (1:1000, Abcam), rabbit-anti-
active CaMKII (pT286; 1:500, Promega, Wisconsin, USA).  
 
Western blotting 
Detection of FZD5 and CaMKII protein expression was performed by Western 
blotting and is described in the supplement. 
 
Immunohistochemistry and Immunofluorescence 
Details about immunohistochemistry and immunofluorescence experiments are given 
in the supplement. Fluorescent signal intensity was quantified using SigmaScan-Pro 
software (Systat-Software Inc., San Jose, CA, USA). 
 
Quantitation of secreted cytokines 
Measurement of secreted IL-6, IL-8, IL-1β and MIP-1β is  described in the 
supplement. 
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Immunoprecipitation of Wnt5A in sera 
Detection of Wnt5A in the sera of septic patients and healthy individuals was 
performed by immunoprecipitation as described in the supplement. 
 
Generation of small interfering RNA (siRNA) and transfection of macrophages 
Wnt5A siRNA silencing experiments were performed as described in the supplement. 
 
Statistical analysis 
Data were analyzed with the use of Graphpad-Prism version 4.0 statistical software. 
We used an unpaired 2-tailed student t test or, for comparison of data among groups, 
one-way ANOVA followed by the Newman–Keuls test. p values <0.05 were 
considered statistically significant.  
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RESULTS 
Identification of targets for the anti-inflammatory action of IL-10 and APC by 
gene expression profiling 
To define novel targets for anti-inflammatory intervention, preferably at an early stage 
of the inflammatory response, we applied microarray based comparative 
transcriptome analysis in our model of monocyte derived macrophages. 
The mRNA expression profiles of macrophages incubated with LPS/INFγ with or 
without IL-10 or APC for 8 h were compared with the expression profiles of untreated 
macrophages (common reference, cultured in parallel) by competitive two-color 
hybridization on human whole genome oligonucleotide array chips. The cytokine IL-
10, that has well described anti-inflammatory properties, was used to compare its 
effect with the suspected but not elucidated, anti-inflammatory action of APC in our 
setting of inflammatory activated macrophages. Analysis of experiments with 
macrophages from three different donors revealed a set of genes induced by 
LPS/INFγ (see supplemental material, Table I, available online at 
http://atvb.ahajournals.org). Complete data are available in the ArrayExpress 
database with the following accession number, E-MEXP-927. In addition to several 
known inflammatory genes such as IL1β (87-fold induction compared to untreated 
cells), IL6 (15-fold), IL8 (3-fold), CCL2 (17-fold) and CCL4 (14-fold), Wnt5A was 
strongly induced by LPS/INFγ (79-fold, see supplemental table I). Anti-inflammatory 
stimuli reduced Wnt5A induction 2.7-fold by APC and 4.2-fold by IL-10 (Supplemental 
Figure I, available online at http://atvb.ahajournals.org). Furthermore, the FZD5 and 
CaMKII genes, which encode proteins involved in Wnt signaling pathways, were also 
differentially expressed. Both the genes for the receptor FDZ5 and for the signaling 
enzyme CaMKII are not upregulated by LPS/INFγ in presence of APC or IL10.  
 
IL-10 and APC regulate the Wnt5A/Ca2+ pathway at the mRNA expression and 
protein level. 
Quantitative RT-PCR verified that the expression and regulation of Wnt5A mRNA 
was induced by LPS/INFγ in human macrophages and that the level of induction of 
Wnt5A mRNA was reduced by the action of IL-10 and APC (Figure 1a). 
Transcriptional expression of Wnt5A was maximal at 8h in activated macrophage and 
declined rapidly within 24-48h to normal levels compared to unstimulated cells (data 
not shown). To test whether Wnt5A is also induced by signals targeting Toll-like 
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receptors (TLR), we investigated a representative array of TLR agonists targeting 
TLR 1–9, and found that only PamCSK4 (TLR 1/2 agonist) and Imiquimod (TLR 7 
agonist) did not induce Wnt5A mRNA transcription. All other TLR agonists induced 
Wnt5A expression more than 10-fold (Figure 1b). Immunocytochemistry was used to 
assess the levels of accumulated Wnt5A protein in activated macrophages (Figure 
1c). After 24 h incubation with LPS/INFγ, Wnt5A protein expression had increased in 
macrophages compared with untreated control cells. In contrast, after treatment with 
LPS/INFγ/IL-10 or LPS/INFγ/APC Wnt5A protein expression was unchanged in 
macrophages compared to untreated control cells (see Figure 1d). This observation 
leads us to the assumption that Wnt5A expression is induced by LPS/INFγ and that 
this effect is suppressed by IL-10 and APC. 
 
FZD5 and CaMKII are present and contribute to Wnt5A signaling in 
macrophages that can be blocked by a sFRP1 
Western blot analysis showed FZD5 and CaMKII expression in macrophages, 
providing further evidence that these important components of the Wnt5A signaling 
pathway are present (Figure 2a). FZD5 protein was present as a single band with a 
molecular weight of 250 kDa. There were no detectable differences in the amount of 
protein in response to different treatments. CaMKII was present as a single band with 
a molecular weight of 60 kDa. Although it was not possible to establish whether the 
amount of CaMKII protein increased in macrophages stimulated with LPS/INFγ, 
CaMKII protein expression clearly decreased due to the action of APC. To address 
CaMKII activation by Wnt5A, we used a specific polyclonal antibody that recognizes 
only the phosphorylated form of CaMKII. Activation of CaMKII by Wnt5A and by 
LPS/INFγ was confirmed by immunofluorescence in cultured macrophages (Figure 
2b and c). To corroborate our evidence for the contribution of Wnt5A to the 
inflammatory response of human macrophages, we blocked Wnt5A signaling at the 
ligand/receptor stage. sFRP1 is a member of the sFRP family that contains a 
cysteine-rich domain homologous to the putative Wnt binding site of Frizzled proteins 
and it can act as a soluble modulator of Wnt signaling by specifically binding to 
Wnt5A21. Incubating macrophages with sFRP1 in addition to LPS/INFγ or 
recombinant Wnt5A reduced CaMKII phosphorylation, indicating that the Wnt5A 
signaling pathway was activated by inflammatory stimuli and that  sFRP1 blocked this 
activation by preventing binding of Wnt5A to its receptor, FZD5 (Figure 2b, c). 
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Wnt5A stimulates the release of pro-inflammatory cytokines in macrophages, 
and IL-10 or APC block the inflammatory action of Wnt5A 
The biologic response of macrophages to an inflammatory stimulus is the synthesis 
and secretion of an array of inflammatory cytokines and chemokines. In a next series 
of experiments we wanted to know if Wnt5A itself could account for a comparable 
effect on inflammatory cytokine production as LPS/IFN-γ. To investigate the biologic 
response to Wnt5A we quantified the levels of the proinflammatory cytokines IL-6, IL-
8, IL-1β and MIP-1β in supernatants of macrophage cultures treated for 24h with 
recombinant mouse Wnt5A. As shown in Fig. 3, recombinant Wnt5A, expressed in a 
mammalian cell system and without detectable endotoxin concentrations (see 
method section), did indeed stimulate the release of pro-inflammatory cytokines in 
macrophages (black bars) in a comparable manner to cells that were stimulated with 
LPS/INF-γ (data not shown). Furthermore, IL-10 (grey bars) or APC (open bars) 
prevented the inflammatory cytokine release upon stimulation with Wnt5A (Figure 3). 
There were again common and distinct effects of IL-10 and APC. The anti-
inflammatory effects of IL-10 and APC were comparably strong reducing IL-1 and 
MIP-1 production, while the effect of APC on IL-6 or IL-8 production was not as 
impressive as IL-10.  
 
Blocking Wnt5A signaling influences the expression of inflammatory cytokines 
To examine the Wnt5A contribution to the inflammatory response in macrophages 
further, we generated small interfering RNA (siRNA) against Wnt5A by transcription 
and dicing of a human Wnt5A specific template and investigated whether inhibition 
by siRNA of Wnt5A transcription influences the transcription and secretion of 
inflammatory cytokines. Transfection of unstimulated macrophages with anti-Wnt5A 
siRNA decreased Wnt5A activity by 80%, but did not significantly affect macrophage 
viability (data not shown). However in LPS/INF-γ stimulated macrophages, 
knockdown of Wnt5A significantly decreased transcription of Wnt5A (Figure 4a). To 
ensure specificity of the observed effect of siRNA directed against Wnt5A, we 
measured expression of the housekeeping gene HPRT and found no significant 
change (Figure 4a). Moreover, knockdown of Wnt5A significantly decreased 
transcription and secretion of the inflammatory cytokines IL-1β, IL-6 and IL-8 (Figure 
4b). Transfection with siRNA directed against luciferase GL3 duplex had no effect on 
the response to LPS/INFγ compared to mock-transfected cells (data not shown). 
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These results further support a mechanism by which Wnt5A influences the 
transcription and release of inflammatory cytokines. Because of our previous 
observation that sFRP1 blocked CaMKII phosphorylation induced by LPS/INFγ 
stimulation we incubated stimulated human macrophages with sFRP1. We verified 
that sFRP1 inhibited the release of IL-1β, IL-6, IL-8 and MIP-1β in macrophages 
cultured under inflammatory conditions, which confirms that Wnt5A signaling caused 
secretion of pro-inflammatory cytokines (Figure 4c). 
 
Wnt5A protein is present in the serum and bone marrow of patients with severe 
sepsis or septic shock 
Due to the high levels of Wnt5A induced by inflammatory stimuli in vitro, we 
determined whether Wnt5A is present in vivo. Because Wnt5A is secreted, we 
suggested its presence in sera of septic patients. Thus we performed 
immunoprecipitation in archive sera samples  from patients with severe sepsis or 
septic shock defined according to the criteria set forth by the 2003 International 
Sepsis Definitions Conference16 using a Wnt5A specific polyclonal antibody. 
Supernatants of transfected cells expressing and secreting large amounts of Wnt5A16 
served as controls (Figure 5a). Densitometric analysis showed a distinct difference 
between the amounts of Wnt5A protein in patient samples compared with sera from 
healthy individuals (Figure 5b). Wnt5A concentration in sera of patients could be 
affected by kidney failure or disturbances of liver function, which occur often in 
patients with severe sepsis or septic shock. Serum creatinine concentrations were 
normal in all sera tested. In addition, neopterin, a marker of activated human 
macrophages was significantly elevated only in the sera of sepsis patients (Figure 
5b). The finding of elevated Wnt5A in sera of patients suggests an active role for 
secreted Wnt5A in the pathophysiology of sepsis. To confirm this observation, we 
demonstrated Wnt5A expression in macrophages of bone marrow samples of 
patients with fatal sepsis17. Immunohistochemical analysis showed that there was 
intense staining for Wnt5A in hemophagocytic macrophages in these patients 
compared with bone marrow from healthy individuals. Again, sections of Wnt5A 
expressing cells and L-cells served as positive and negative controls, respectively, as 
they were fixed and stained in the same manner. The intensity of Wnt5A staining in 
the untransfected L-cells (background staining) was comparable to that found in bone 
marrow sections of healthy individuals (Figure 5c).  
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DISCUSSION 
In this study we found that expression of Wnt5A is pivotal in a pathway involved in 
sustained inflammatory macrophage activation during sepsis. Our initial studies 
aimed to identify novel targets of the anti-inflammatory activity of APC in 
pharmacological doses used in sepsis patients, in macrophages.  
Beyond modulation of coagulation activation, the pleiotropic anti-inflammatory 
activities of APC that are directed to different cellular targets are proposed to 
contribute to the uniquely beneficial activity of this agent in patients with severe 
sepsis. In a genome wide transcriptional screen of macrophages stimulated with LPS 
and IFN-γ, we have identified Wnt5A as one of the most highly induced genes. 
Suppression of inflammation-forced Wnt5A expression by APC and IL-10 implicated 
Wnt5A in an active role in the inflammatory response. Both the inflammatory driven 
transcriptional expression of Wnt5A and its suppression by APC and IL-10 were 
confirmed by independent methods at the mRNA and protein levels. Furthermore, 
high levels of immunoprecipitatable Wnt5A in sera from patients with severe sepsis 
provided direct evidence of an active role for secreted Wnt5A in the pathophysiology 
of the systemic inflammatory response during sepsis. Although our studies did not 
intend to identify the cellular source of Wnt5A secretion during sepsis, demonstration 
of Wnt5A positive macrophages within the bone marrow of patients with fatal sepsis 
suggests that activated macrophages play an important role in this disease setting. 
Recently a distinct role for Wnt family members in inflammation and immunity has 
been recognized. The Drosophila Wnt protein family member WntD regulates the 
innate immune response to infection in the fly14. In these studies, WntD expression is 
shown to be controlled by Toll signaling, a highly conserved pathway known to 
induce antimicrobial and inflammatory responses also in the human macrophage. 
Furthermore, WntD signaling in the fly was independent of the common beta-catenin 
pathway, as it is the case in the inflammatory human macrophage system described 
herein. Moreover, WntD was identified as the first secreted regulator of Toll signaling 
in the fly. This is in line with an earlier study that described Wnt5A being secreted by 
activated antigen presenting cells and by inflammatory synoviocytes from rheumatoid 
arthritis joints19. This was the first report of Wnt5A expression associated with an 
inflammation in humans. However, It became unclear in this study, how Wnt5A 
expression was linked with inflammatory cytokine production, because the signaling 
of Wnt5A through FFZD5 was not delineated. More recently, Wnt5A expression is 
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shown to be induced by mycobacterial cell wall components and endotoxin in human 
antigen presenting cells and is dependent on activation of the central inflammatory 
regulator NF-κB15. In this report it is clearly shown that Wnt5A expression required 
Toll-like receptor (TLR)2 and TLR4-dependent signaling. This finding is completely in 
line with the finding of TLR dependent WntD expression in the fly, indicating that 
these pathways are linked together and are highly conserved throughout species. 
However, it was not elucidated whether activation of other TLRs induce Wnt5A or 
other Wnt homologues15. Our study extends the idea that Wnt5A secretion 
constitutes a highly conserved response to inflammatory macrophage activation by 
demonstrating that Wnt5A mRNA is not only induced by LPS and the classical 
macrophage stimulator INFγ, but also by a representative array of TLR agonists 
targeting TLR 1–9. 
After secretion, Wnt5A is proposed to act by ligation to its receptor FDZ5, which we 
and others have shown to be expressed in human macrophages15. It was however 
not clear which pathway of Wnt5A signaling was involved in macrophages in the 
setting of inflammatory activation. Different signaling pathways may be triggered 
subsequently by Wnt5A/FDZ5. The canonical signaling pathway acts by enhancing 
the intracellular level of β-catenin. This canonical pathway is the most intensively 
studied pathway of Wnt action in cell development and differentiation. We were 
unable to detect any evidence for canonical signaling in our inflammatory activated 
macrophages. The non-canonical Wnt signaling pathway elucidated in the present 
study induced a rise in intracellular calcium levels and activated CaMKII, which, 
among other effects, leads to activation and nuclear translocation of the transcription 
factor NF-AT20. Cell specific characteristics and the co-receptor environment in 
particular, determine which of these pathways are activated upon ligation of a frizzled 
receptor with its Wnt ligand. Ca2+ release and the associated phosphorylation of 
CamKII are extensively studied signaling events that are critically involved in 
macrophage activation21, 22. Our finding that recombinant Wnt5A increased 
phosphorylation of CamKII provides experimental evidence that Wnt5A is capable of 
activating the pro-inflammatory Ca2+/CamKII pathways in macrophages. This effect is 
completely abrogated by sFRP1, a soluble Wnt binding protein that specifically binds 
to and impairs Wnt5A interaction with its cognate cell surface receptor18. This implies 
that a specific Wnt5A/FDZ5 interaction mediates the Wnt5A activity observed in our 
experiments and excludes nonspecific effects imparted by small molecular 
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contaminants such as endotoxin. Again, this is fully in line with the findings of others 
that FDZ proteins are receptors for Wnt and that Wnt signaling is modulated by the 
specific cysteine-rich domain of soluble frizzled related peptides.18 Our finding, that 
sFRP1 also inhibited the LPS/IFN-γ induced CamKII phosphorylation, implies a 
causal link between Wnt5A secretion triggered by inflammation and LPS/IFN-γ 
induced macrophage activation. Again, this Wnt5A/FDZ5 mediated activation of the 
non-canonical signaling pathway may thus act as a positive regulatory mechanism 
that sustains and enhances inflammatory macrophage activation induced by 
exogenous pro-inflammatory agents. Our finding that Wnt5A activates the non-
canonical signaling pathway in macrophages is compatible with its capacity to exert 
inflammatory effects in rheumatoid synoviocytes and in antigen presenting cells. 
Furthermore, treatment of macrophages with exogenous Wnt5A initiated secretion of 
inflammatory cytokines in our study. However, the subsequent observation that 
Wnt5A knockdown by siRNA significantly decreased the transcription and secretion 
of inflammatory cytokines and that inhibition of autocrine Wnt5A signaling by sFRP1 
almost completely reversed LPS/INFγ induced cytokine secretion suggests that 
Wnt5A is not just another inflammatory macrophage activator but also a pivotal 
regulator of macrophage activation during inflammation. In light of the findings in the 
septic fly model, where Wnt is critically involved in the control of infection, the findings 
of induced Wnt5A upon mycobacterial infection of human monocytes, and the 
identification of Wnt5A in inflamed synoviocytes of rheumatoid arthirtis, our present 
findings suggest that Wnt5A is a highly specific autocrinous and paracrinous 
macrophage derived effector molecule triggering inflammation through a well defined 
pathway. Therefore, our results suggest that the Wnt5A pathway is an attractive 
candidate target for therapeutic intervention in inflammatory diseases such as sepsis 
or rheumatoid arthritis. First, significant amounts of Wnt5A are secreted in septic 
patients. One could well assume from this finding and from the observations of 
Wnt5A being released by synoviocytes19 that Wnt5A is elevated also in the sera of 
rheumatoid arthritis patients. Second, interference with the Wnt5A signaling pathway 
acts at an early step in macrophage activation. The data from this study together with 
previous evidence17 suggests that Wnt5A signaling constitutes a non-redundant 
activation pathway, which might be indispensable for sustained inflammatory 
macrophage activation. Third, we show that expression of Wnt5A constitutes a highly 
conserved response to macrophage activation triggered by a wide array of ligands 
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involved in initiation of systemic inflammation. This in turn implicates Wnt5A signaling 
in a final common pathway of macrophage activation. Fourth, the fact that Wnt5A is a 
secreted protein and that Wnt5A signaling involves classical receptor–ligand 
interactions raises the possibility of modulation of Wnt5A activity in vivo. Application 
of soluble Wnt5A neutralizing molecules, as applied in our work, thereby represents 
just one possibility for achieving in vivo suppression of inflammatory Wnt signaling. 
While our results suggest that the development of Wnt antagonists might be a 
valuable strategy for controlling inflammation at one of its critical checkpoints, partial 
Wnt control during sepsis may yet be achieved by treatment with APC, which acts by 
downregulation of Wnt5A expression and thus by modulating inflammatory Wnt 
activity. 
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FIGURE LEGENDS 
Detailed information to each figure is given in the supplement (available as 
supplemental data) 
 
Figure 1. Wnt5A expression is induced by LPS/INFγ and TLR agonists and is 
blocked by IL-10 and APC. 
(a and b) Wnt5A mRNA of unstimulated (control) or macrophages treated with the 
indicated stimuli. (c) Immunofluorescence of Wnt5A protein in macrophages treated 
for 24 h with the indicated stimuli. (d) Quantitative fluorescence signal intensity of 
Wnt5A in control and activated macrophages. 
 
Figure 2. The Wnt5A signaling pathway is active in macrophages and is 
blocked by sFRP1. 
(a) Detection of CaMKII and FZD5 protein in lysates of cultured macrophages treated 
with LPS, INFγ, IL-10 and APC, as indicated, for 24 h. (b) Immunofluorescent 
detection of phosphorylated CaMKII. (c) Quantitative fluorescence signal intensity of 
phosphorylated CaMKII in control and treated macrophages.  
 
Figure 3. Induction of inflammatory cytokine secretion by Wnt5A signaling, its 
modulation by anti-inflammatory mediators IL-10 and APC. 
Concentrations of IL-6, IL-8, IL-1β and MIP-1β protein secreted by macrophages 
treated with Wnt5A in the absence and the presence of IL-10 or APC, respectively.  
 
Figure 4. Effect of blocking Wnt5A signaling with siWnt5A on inflammatory 
cytokines secretion 
(a) Left graph, fold induction of Wnt5A mRNA expression in LPS/INFγ stimulated 
macrophages after transfection with siWnt5A. Right graph, HPRT mRNA expression 
in LPS/INFγ stimulated macrophages after transfection with siWnt5A (b) IL-6, IL-8, 
IL-1β mRNA expression and secretion by LPS/INFγ stimulated macrophages after 
transfection with siWnt5A. (c) Concentrations of IL-6, IL-8, IL-1β and MIP-1β 
secreted by macrophages. Cells were stimulated with LPS/INF in the absence or 
presence of sFRP1.  
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Figure 5. Wnt5A protein is present in the serum and bone marrow of patients 
with severe sepsis or septic shock. 
(a) Immunoprecipitation of Wnt5A in serum from patients with sepsis (lanes 5–8) and 
from healthy individuals (lanes 1–4). Lane 9 shows Wnt5A conditioned medium 
(Wnt5A-CM) that was immunoprecipitated following the same protocol. (b) Left 
graph, densitometric analysis of bands detected by immunoprecipitation. (c) Wnt5A 
in sections from bone marrow biopsies of patients with fatal sepsis and from healthy 
individuals17 was detected by immunohistochemistry as described in Methods.  
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FIGURE 1 
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FIGURE 2 
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FIGURE 3 
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FIGURE 4 
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FIGURE 5 
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SUPPLEMENTAL MATERIAL 
 
MATERIALS AND METHODS 
 
Cell culture 
Human macrophages were prepared from buffy coats of healthy blood donors (Swiss 
Red Cross, Zurich, Switzerland), by a strictly standardized protocol. Briefly, after 
separation by Ficoll gradient (Ficoll-PaqueTM PLUS, Amersham Biosciences) and 
three washes with Mg2+/Ca2+-free phosphate-buffered saline (PBS; Gibco Europe), 
cells were suspended in Iscove’s modified Dulbecco’s medium (IMDM; Invitrogen 
Europe) supplemented with 10% heat-inactivated pooled human serum (Human 
Serum, off the clot; PAA, Austria) and seeded at a density of 107 cells/mL in 6-well 
tissue culture plates (Falcon Oxnard, USA). Macrophages  were obtained at a purity 
of >98% (determined by Giemsa staining) after 2 h incubation under standard cell 
culture conditions (37°C, 5% CO2) in a SteriCult tissue culture incubator (Forma 
Scientific, USA). The cells were washed four times in warmed Gey’s balanced salt 
solution and incubated for 24 h as before. Medium was then replaced by IMDM 
supplemented with 2% human pooled serum and cells were cultured for 48 h. For the 
last 8 h or 24 h cells received the following treatments prior to mRNA or protein 
expression analysis respectively: 100 U/mL human recombinant IFNγ, 5 ng/mL IL-10 
(both from PeproTech, Rocky, Hill, USA); 10 ng/mL LPS (from Escherichia coli 
055:B5; Difco Laboratories, Detroit, USA); 5 g/mL human recombinant APC 
(Drotregocin alpha activated; XigrisTM, Eli Lilly, Switzerland); 250 ng/mL recombinant 
mouse Wnt5A, 10 μg/mL recombinant human soluble frizzled-related peptide-1 
(sFRP1: both expressed in chinese hamster ovary cells, no endotoxin detectable, 
from R&D Systems Europe Ltd., Abington, UK); and human TLR 1–9 agonist, 5 μM 
oligodeoxynucleotides (ODN), 0.5 μg/mL ssRNA40/LyoVec, 0.5 μg/mL Imiquimod, 
500 ng/mL FSL1, 5 μg/mL Flagellin, 25 μg/mL Poly I:C, 108 cells/mL HKLM and 
0.5 μg/mL PamCSK4 , 10 ng/mL E.coli K12 LPS (tlrl-kit, InvivoGen, USA). 
 
DNA microarray hybridization and analysis 
Differential gene expression profiling of human macrophages was performed by 
competitive dual-color hybridization of cRNA probes with untreated and treated cells 
cultured for 48 h on human 44k 60-mer oligonucleotide microarray chips (Agilent 
Technologies Schweiz AG, Basel, Switzerland). Total RNA was purified using the 
RNeasy Mini Kit protocol (Qiagen AG, Hombrechtikon, Switzerland ) with on-column 
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DNase digestion according to the manufacturer’s instructions. For quality control 
purposes and to quantify samples, each RNA sample (1 μL) was analyzed on RNA 
6000 Nanochips using a Bioanalyzer 2100 instrument and 2100 Expert software 
(Agilent Technologies,). High quality total RNA typically had an 18/28S ribosomal 
RNA ratio >1.5 and was stored frozen in aliquots at –70°C. Labeled cRNA probes 
were synthesized from 1 μg total RNA using the Low RNA Input Fluorescent Linear 
Amplification Kit (Agilent Technologies) and cyanine-3-CTP or cyanine-5-CTP 
(Amersham Biosciences Europe GmbH, Freiburg, Germany). Labeled cRNA probes 
were purified on RNeasy Mini Spin Columns (Qiagen) and quantified in a NanoDrop 
spectrophotometer (NanoDrop Technologies, Inc. Anaheim, USA). Equal quantities 
of Cy3- and Cy5-labeled probes (1 μg of each) were mixed, spiked with control 
targets and incubated in fragmentation buffer for 30 min at 60°C in the dark. After 
fragmentation, the gasket slides were completely filled with the respective probe 
mixtures. The hybridization chambers were assembled with Human 1A Oligo 
Microarray slides (Agilent Technologies) and hybridized for 17 h at 60°C in the dark 
with mixing at 4 rpm. After washing twice in SSPE/N-Lauroylsarcosine for 1 min, the 
slides were carefully washed in acetonitrile for exactly 30 sec and dried. Finally, 
slides were directly scanned using a dual-laser microarray scanner and analyzed with 
Feature Extraction software (Agilent Technologies). Data mining was achieved using 
the Rosetta Resolver Gene Expression Data Analysis System (Rosetta Biosoftware, 
Seattle, USA, www.rosettabio.com). 
 
RNA isolation and quantitative real-time reverse transcription PCR (RT-PCR) 
Total cellular RNA was isolated using the Qiagen RNeasy Mini Kit (Qiagen, Basel, 
Switzerland), which included a DNase digest. Total RNA was quantified 
spectrophotometrically and equal amounts (5 μg) were transcribed into cDNA with 
oligo(d)T primers and StrataScript RT Reverse Transcriptase using the StrataScript 
First-Strand Synthesis System (Stratagene, Rotkreuz, Switzerland). Duplicates of 
cDNA were amplified by RT-PCR with gene-specific primers using the 7500 Fast 
Real-Time PCR system (Applied Biosystems, Inc., Rotkreuz, Switzerland) and the 
Power SYBR Green Master Mix (Applied Biosystems). Sequence-specific primers 
were selected using Primer Express v2.0 software (Applied Biosystems). The 
following primers were employed for Wnt5A and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH): Wnt5A forward, 5'-AGT TGC CTA CCC TAG C-3'; Wnt5A 
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reverse, 5'-GTG CCT TCG TGC CTA T-3'; GAPDH forward, 5'-AAC AGC GAC ACC 
CAC TCC TC-3'; GAPDH reverse, 5'-GGA GGG GAG ATT CAG TGT GGT-3'. 
Primers for cytokines were as follows: IL1β-forward, 5’-CAG AAA ACA TGC CCG T-
3’, IL1β reverse, 5’GCA CTA CCC TAA GGC AG-3’, IL6 forward, 5’-CCT GAC CCA 
ACC ACA AA-3’, IL6 reverse, 5’-AGT GTC CTA ACG CTC ATA C-3’, IL8 forward, 5’-
AGA CAG CAG AGC ACA CAA GC-3, IL8 reverse, 5’-ATG GTT CCT TCC GGT 
GGT-3’, HPRT forward, 5’-GAC TGT AGA TTT TAT CAG ACT GA-3’, HPRT reverse, 
5’-TGG ATT ATA CTG CCT GAC CAA-3’. PCR was carried out with an initial 
denaturation step (10 min, 95°C) followed by 40 cycles of denaturation (15 sec, 
95°C), annealing (30 sec, 55°C), and extension (30 sec, 72°C). Fluorescence was 
measured at the end of each extension. Relative mRNA levels were quantified by RQ 
Study SDS Software v1.3.1 (Applied Biosystems) using the comparative Ct method. 
The expression level of each gene was normalized to GAPDH levels in each 
experimental sample. Final data were expressed as mRNA expression in treated 
cells relative to expression in untreated cells. A melting curve analysis was performed 
for each amplicon to verify the specificity of each amplification step. 
 
Western blotting 
For assaying FZD5 and CaMKII protein expression, cells were lysed with Mammalian 
Cell Lysis/Extraction reagent (Sigma-Aldrich Chemical Co., Buchs, Switzerland) 
supplemented with complete mini protease inhibitor cocktail tablets (Roche 
Diagnostics Schweiz AG, Rotkreuz, Switzerland). After clearing the lysates by high-
speed centrifugation, protein concentrations of each sample were determined using a 
Protein Bradford assay (Bio-Rad Laboratories AG, Reinach, Switzerland). For 
immunoblotting, 20 μg total protein of each sample was resolved on SDS 4–15% 
gradient polyacrylamide gels and transferred to PVDF membrane (Millipore AG, Zug, 
Switzerland). After transfer, the membranes were incubated for 1 h in blocking 
solution (5% non-fat milk in PBS containing 0.1% Tween-20) and then 1 h with the 
respective antibody in blocking solution. Antibody binding was detected with a 
horseradish peroxidase-coupled donkey-anti rabbit secondary antibody diluted 
1:10’000 followed by enhanced chemiluminescence (ECL) detection (ECL Plus, 
Amersham Pharmacia Biotech, Inc., Uppsala, Sweden). 
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Immunofluorescence staining 
For immunofluorescent microscopic analysis of Wnt5A protein expression, 
macrophages were grown on sterile, endotoxin-free 12 mm glass coverslips 
pretreated with poly-D-Lysine (Invitrogen AG, Basel, Switzerland). In brief, 100 µL of 
a 2 x 108 cells/mL mononuclear cell suspension were seeded on coverslips in 24-well 
cluster plates, incubated in IMDM/10% pooled human serum for 2 h under standard 
cell culture conditions, washed and cultured for 48 h with and without stimuli as 
described above. After incubation, coverslips were fixed with 3% paraformaldehyde 
for 15 min and permeabilized with 0.1% Triton X-100. The coverslips were then 
exposed to primary antibodies for 60 min, followed by Alexa 594 labeled rabbit anti-
goat or Alexa 488 labeled goat anti-rabbit (1:1000: Molecular Probes, Invitrogen 
Europe), for 60 min. Coverslips were washed three times with PBS, pH 7.4, after 
each antibody incubation. Nuclei were counterstained with 10 μg/mL diamidino-
phenylindole (DAPI; Sigma-Aldrich). Images were taken with an Axioskop 2 
microscopy system equipped with an AxioCam MRc digital camera using AxioVision 
v4.4 software (Carl Zeiss, Feldbach, Switzerland). For quantification of 
immunofluorescent signals, 5 images were registered for each treatment and were 
analysed using SigmaScan Pro software (San Jose, CA, USA).. 
 
Immunohistochemical staining 
Bone marrow samples were retrieved from the archives of the Department of 
Pathology of the University Hospital Zurich. They consisted of autopsy samples from 
patients that had died from severe sepsis or septic shock according to the criteria set 
forth by the 2003 International Sepsis Definitions Conference1. Autopsy samples from 
patients that had died from gun-shot suicides (age 31–88 yr) served as controls. 
Microtome sections (4 μm) were cut from formalin-fixed, decalcified and paraffin-
embedded marrow samples. Immunohistochemistry was performed on an automated 
immunohistochemistry module (Bond (TM), Vision BioSystems., Newcastle Upon 
Tyne, UK) using affinity purified WNT5A polyclonal goat antisera (R&D Systems, 
Minneapolis; USA), diluted 1: 120 for 60 min followed by the Bond polymer system 
using diaminobenzidine for visualization. Pretreatment for heat induced epitope 
retrieval was carried out for 30 min with the EDTA based pH8.8 Bond Epitope 
Retrieval Solution 2 (Vision BioSystems). Nuclei were counterstained with 
hematoxylin for bright-field microscopy. Cross-species experiments were performed 
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to rule out the possibility of non-specific binding of the secondary antibodies. As 
additional positive and negative controls for Wnt5A immunohistochemistry, we used 
sections prepared from a 1:10 mixture of regular L-cells (no Wnt5A overexpression) 
and Wnt5A transfected L-cells (ATCC, CRL-2648/CRL-2814). Cell pellets were 
formalin-fixed, paraffin-embedded and stained in parallel to the human bone marrow 
samples. 
 
Quantitation of secreted cytokines 
The inflammatory cytokinesIL-1β, IL-6, IL-8, and MIP-1β were quantified in undiluted 
cell culture supernatants collected 24 h after treatment using the Bio-Plex Human 
Cytokine Multiplex Assay on the Bio-Plex 2200 platform according to the 
manufacturer’s instructions (Bio-Rad, Hercules, USA). After preparation and culture 
in IMDM/10% human serum for 24 h, medium was changed to IMDM/2% human 
serum and cells were treated for an additional 24 h with the stimuli outlined above 
(see Cell culture section). Complete medium containing 2% human serum was used 
as a blank. Data were analyzed on the Bio-Plex Reader using Bio-Plex v3.0 software 
(Bio-Rad, Hercules, USA). 
 
Immunoprecipitation of Wnt5A in sera 
Archived serum samples from patients with severe sepsis or septic shock (as above 
according to the criteria set forth by the 2003 International Sepsis Definitions 
Conference1, n = 5; average age 34 years, range 18–62) and from healthy individuals 
(n = 5; average age 30 years, range 25–45) were stored frozen at –70°C until 
analysis. None of the patients with sepsis or septic shock had received APC 
(Drotregocin alpha activated; XigrisTM, Eli Lilly, Switzerland). 
Aliquots of sera (300 µL) from patients and healthy individuals were incubated with 
2 g of anti-Wnt5A (R&D Systems Europe Ltd., Abington, UK) overnight at 4°C and 
then adsorbed to protein G beads (Sigma-Aldrich) overnight at 4°C. Samples were 
washed twice with 1 x IP buffer (Sigma-Aldrich) containing 0.5 M NaCl, four times 
with 1 x IP buffer and once with 0.1 x IP buffer. Finally, samples were eluted with 
Laemmli sample buffer (Bio-Rad). The eluate was analyzed by 10% SDS–
polyacrylamide gel electrophoresis and Western blot onto PVDF membranes 
(Millipore) using the same anti-wnt5A antibody and chemiluminometric detection as 
described above. 
 76
  
To investigate the inflammatory status of the sera and to exclude impaired clearance 
of Wnt5A , due to renal insufficiency in patients with sepsis we analyzed neopterin, a 
common inflammatory metabolite released by activated macrophages2 and serum 
creatinine. Neopterin was measured by HPLC for pteridins after oxidation as 
described previously3.check references Creatinine was measured by ISO certified 
analysis using kinetic Jaffe reaction and a Beckman Unicel DXC 600 analyser. 
Protein was measured by Protein Bradford assay (BioRad). 
 
Generation of small interfering RNA (siRNA) and transfection of macrophages.  
Template DNA probe specific for human Wnt5A (RZPDp3000B068D) was obtained 
from RZPD (Berlin, Germany). From this probe, double-stranded RNA was 
synthesized with T7 enzyme, and 22 bp small interfering RNA probes (siRNA) 
directed against Wnt5A were prepared by dicing using the X-tremeGENE siRNA 
Dicer kit (Roche Diagnostics, Germany) according to the manufacturer’s instructions. 
The siRNA was column-purified and RNA concentrations were measured with a 
NanoDrop spectrophotometer. Human macrophages were transfected for 5 hr at 
37°C with 2.0 μg siRNA with the X-tremeGENE siRNA transfection reagent (Roche 
Diagnostics) in IMDM with 10% human pooled serum. Cells were then washed and 
incubated in IMDM/10% human pooled serum with 100 U/mL INFγ and 1 ng/mL LPS 
for 8 h (optimal time for mRNA expression) or 24 h (optimal time point for protein 
secretion). siRNA directed against luciferase GL3 duplex (Dharmacon, Lafayette, 
USA) served as both transfection and negative control. To ensure specificity of the 
observed effect of siRNA directed against Wnt5A, we measured expression of the 
housekeeping gene HPRT using the primers and PCR conditions as described 
above. 
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RESULTS 
 
FIGURE I 
 
 
 
Figure I. Gene expression profile analysis of human macrophages.  
Human macrophages were cultured as described in Methods. They were treated with 
LPS (10 ng/mL) and INFγ (100 U/mL) for the last 8 h in culture and the differential 
mRNA transcription pattern was characterized by oligonucleotide microarray with 
Agilent 44k gene chips and analysis using Rosetta Biosoftware as described in 
supplemental material. The ratio plot displays combined results from three 
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independent experiments (mean  SD of selected genes). The x-axis (Log intensity) 
shows baseline gene expression and the y-axis (Log ratio) shows the ratio of the 
signal intensities in the two hybridized samples. Individual genes are represented as 
blue (significantly upregulated, p0.001), green (significantly downregulated, 
p0.001). Selected genes (Wnt5A, CaMKII and FZD5) are shown in red. (b) Re-ratio 
plot of human macrophages treated with LPS/INFγ and IL-10 (5 ng/mL) versus 
human macrophages treated with LPS/INFγ. Plots represent combined results from 
three independent experiments, each. The re-ratio analysis tool of Rosetta 
Biosoftware was used for direct comparison between two samples that were 
hybridized against a common reference. (c) Re-ratio plot of human macrophages 
treated with LPS/INFγ and APC (5 μg/mL) versus human macrophages treated with 
LPS/INFγ for 8h. 
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Table I 
Selected genes related to inflammation that are upregulated in human macrophages 
treated with LPS/INFγ. Influence of IL10 or APC on the expression of these genes. 
 
Fold Change Sequence 
Name(s) 
Accession # Sequence 
Description LPS/INF 
vs 
Untreated 
control 
LPS/INF/IL10 
vs LPS/INF # 
LPS/INF/APC 
vs LPS/INF # 
IL1B NM_000576 Homo sapiens 
interleukin 1, beta  
+87.9 -1.5 +1.2 
WNT5A NM_003392 Homo sapiens 
wingless-type 
MMTV integration 
site family, member 
5A  
+79.2 -4.2 -2.7 
CCL2 NM_002982 Homo sapiens 
chemokine (C-C 
motif) ligand 2  
+17.1 -1.1 -1.0 
IL6 NM_000600 Homo sapiens 
interleukin 6 
(interferon, beta 2) 
+15.3 -6.0 -1.8 
CCL4 NM_002984 Homo sapiens 
chemokine (C-C 
motif) ligand 4  
+13.9 -1.6 +1.0 
IL8 NM_000584 Homo sapiens 
interleukin 8 
+3.6 -1.9 -1.9 
CaMK2D NM_172127 Homo sapiens 
calcium/calmodulin-
dependent protein 
kinase (CaM 
Kinase) II delta 
+2.4 -1.5 +1.0 
FZD5 NM_003468 Homo sapiens 
frizzled homolog 5 
(Drosophila) 
+1.2 +1.4 -1.0 
 
Fold changes (up or down) of gene expression were calculated using the ratio or re-
ratio# function of Rosetta Biosoftware that allows direct comparison between two 
samples that were both hybridized against a common reference. Data are from three 
independent experiments, p < 0.001.  
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Table II 
 
Wnt family members and Wnt pathway related gene expression in human 
macrophages treated with LPS/ INFγ versus untreated cells (p<0.001) 
 
 
Sequence 
Name(s) 
Accession # Sequence Description Fold 
Change 
WISP3 NM_130396 Homo sapiens WNT1 inducible signaling pathway protein 3  +1.6 
WNT8A NM_031933 Homo sapiens wingless-type MMTV integration site family, 
member 8A 
-1.2 
WNT7B NM_058238 Homo sapiens wingless-type MMTV integration site family, 
member 7B  
-1.1 
WNT2 NM_003391 Homo sapiens wingless-type MMTV integration site family 
member 2  
-1.1 
WNT8B NM_003393 Homo sapiens wingless-type MMTV integration site family, 
member 8B  
+1.0 
WIF1 NM_007191 Homo sapiens WNT inhibitory factor 1 +1.2 
WNT4 NM_030761 Homo sapiens wingless-type MMTV integration site family, 
member 4  
+1.2 
WNT1 NM_005430 Homo sapiens wingless-type MMTV integration site family, 
member 1 
-1.0 
WNT9A NM_003395 Homo sapiens wingless-type MMTV integration site family, 
member 9A  
-1.9 
WNT10A NM_025216 Homo sapiens wingless-type MMTV integration site family, 
member 10A  
-1.2 
WNT7A NM_004625 Homo sapiens wingless-type MMTV integration site family, 
member 7A  
-1.8 
WISP2 NM_003881 Homo sapiens WNT1 inducible signaling pathway protein 2  -1.1 
WNT10A NM_025216 Homo sapiens wingless-type MMTV integration site family, 
member 10A  
-1.2 
WNT5B NM_030775 Homo sapiens wingless-type MMTV integration site family, 
member 5B (WNT5B) 
-1.2 
WNT11 NM_004626 Homo sapiens wingless-type MMTV integration site family, 
member 11 
+1.1 
WISP1 NM_003882 Homo sapiens WNT1 inducible signaling pathway protein 1 -1.1 
WNT6 NM_006522 Homo sapiens wingless-type MMTV integration site family, 
member 6 
-1.0 
WNT3A NM_033131 Homo sapiens wingless-type MMTV integration site family, 
member 3A  
+1.1 
WNT3 NM_030753 Homo sapiens wingless-type MMTV integration site family, 
member 3  
-1.2 
WNT9B NM_003396 Homo sapiens wingless-type MMTV integration site family, 
member 9B  
+1.0 
WNT10B NM_003394 Homo sapiens wingless-type MMTV integration site family, 
member 10B  
-1.1 
WNT2B NM_004185 Homo sapiens wingless-type MMTV integration site family, 
member 2B  
-1.9 
WNT16 NM_057168 Homo sapiens wingless-type MMTV integration site family, 
member 16  
+1.0 
WNT7B NM_058238 Homo sapiens wingless-type MMTV integration site family, 
member 7B  
+1.3 
WNT5A NM_003392 Homo sapiens wingless-type MMTV integration site family, 
member 5A  
+79.2 
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DETAILED  FIGURE LEGENDS 
 
Figure 1. Wnt5A expression is induced by LPS/INFγ and TLR agonists and is 
blocked by IL-10 and APC. 
(a) mRNA expression of Wnt5A measured by quantitative RT-PCR. macrophages 
were unstimulated (control) or treated with LPS, INFγ, IL-10, and APC, as indicated. 
Changes in mRNA expression were normalized to changes in GAPDH expression 
and are expressed as mean  SD from three independent experiments. (b) mRNA 
expression of Wnt5A measured by quantitative RT-PCR. Macrophages were 
unstimulated (control) or treated with TLR agonists as follows: 5 μM 
oligodeoxynucleotides (ODN, TLR9), 0.5 μg/mL ssRNA40/LyoVec (TLR8), 0.5 μg/mL 
Imiquimod (TLR7), 500 ng/mL FSL1 (TLR6/2), 5 μg/mL Flagellin (TLR5), 25 μg/mL 
Poly I:C (TLR3), 108 cells/mL HKLM (TLR2), and 0.5 μg/mL PamCSK4 (TLR1/2), 
10 ng/mL E.coli K12 LPS (TLR4), (tlrl-kit, InvivoGen, USA). Data is expressed as 
described in (a). (c) Immunofluorescence staining of Wnt5A protein in macrophages. 
Cells grown on coverslips were treated for 24 h with LPS/INFγ, LPS/INFγ/IL-10 or 
LPS/INFγ/APC, in the same concentrations as used for microarray experiments. 
Fluorescence was visualized using a Zeiss Axioskop 2 fluorescence microscope and 
an AxioCam MRc digital camera using Axiovision v4.4 software. All 
photomicrographs within a series were taken using the same exposure time and 
frame. Magnification, 630X. (d) Quantification of the fluorescence signal intensity of 
Wnt5A. Bars represent total intensity per cell count (mean±S.E.M, n=15 pictures). 
p<0.05 (one-way ANOVA). 
 
Figure 2. The Wnt5A signaling pathway is active in macrophages and is 
blocked by sFRP1. 
(a) Detection of CaMKII and FZD5 protein in lysates of cultured macrophages treated 
with LPS, INFγ, IL-10 and APC, as indicated, for 24 h. (b) Immunofluorescent 
detection of phosphorylated CaMKII. Macrophages were cultured for 24 h prior to 
incubation for 30 min or 120 min with LPS, INFγ, sFRP1 or Wnt5A, as indicated. 
Control cells were untreated. Wnt5A and sFRP1 were mixed and pre-incubated for 
30 min before addition to the cells. Phosphorylated CaMKII was detected using a 
specific anti-active CaMKII antibody (see Methods). Fluorescence was visualized 
using a Zeiss Axioskop 2 fluorescence microscope and an AxioCam MRc digital 
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camera using Axiovision v4.4 software. All photomicrographs within a series were 
taken using the same exposure time and frame. Magnification, 630X. (c) 
Quantification of the fluorescence signal intensity of phosphorylated CaMKII. Bars 
represent total intensity per cell count (mean±S.E.M, n=10 pictures). p<0.05 (one-
way ANOVA). 
 
Figure 3. Induction of inflammatory cytokine secretion by Wnt5A signaling, its 
modulation by anti-inflammatory mediators IL-10 and APC. 
Concentrations of IL-6, IL-8, IL-1β and MIP-1β protein secreted by macrophages 
treated with Wnt5A in the absence and the presence of IL-10 or APC, respectively. 
Control cells were untreated. Cytokines were measured in cell culture supernatants 
collected 24 h after treatment using the Bio-Plex Human Cytokine Multiplex Assay on 
the Bio-Plex 2200 platform. Cytokine concentrations in treated cells were normalized 
to the concentrations in control cells and are presented as mean  SEM from three 
independent experiments. *p<0.05. 
 
Figure 4. Effect of blocking Wnt5A signaling with siWnt5A on inflammatory 
cytokines secretion 
(a) Left graph, fold induction of Wnt5A mRNA expression in LPS/INFγ stimulated 
macrophages after transfection with siWnt5A. Right graph, HPRT mRNA expression 
in LPS/INFγ stimulated macrophages after transfection with siWnt5A The expression 
level was normalized to GAPDH mRNA in each experimental sample. Data are 
presented as mRNA expression in stimulated siWnt5A-(open bar) and mock-
transfected (black bar) cells relative to the expression level in unstimulated 
transfected cells. Results are expressed as mean  SEM of three independent 
experiments. *p<0.05 (b) IL-6, IL-8, IL-1β mRNA expression and secretion by 
LPS/INFγ stimulated macrophages after transfection with siWnt5A. Data are 
presented as mRNA expression in stimulated siWnt5A-(open bar) and mock-
transfected (black bar) cells relative to the expression level in unstimulated 
transfected cells, and as the ratio of the concentration of cytokine secreted by 
stimulated cells to that secreted by unstimulated cells (in siWnt5A or mock 
transfected cells). Results are expressed as mean  SEM of three independent 
experiments. *p<0.05 (c) Concentrations of IL-6, IL-8, IL-1β and MIP-1β secreted by 
macrophages. Cells were stimulated with LPS/INF in the absence or presence of 
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sFRP1. Control cells were untreated. Cytokine concentrations in treated cells were 
normalized to the concentrations in control cells and are presented as mean  SEM 
from three independent experiments. *p<0.05. 
 
Figure 5. Wnt5A protein is present in the serum and bone marrow of patients 
with severe sepsis or septic shock. 
(a) Immunoprecipitation of Wnt5A in serum from patients with sepsis (lanes 5–8) and 
from healthy individuals (lanes 1–4). Lane 9 shows Wnt5A conditioned medium 
(Wnt5A-CM) that was immunoprecipitated following the same protocol. The 
molecular weight of the band visualized corresponds to ~40 kDa, as expected for 
Wnt5A. (b) Left graph, densitometric analysis of bands detected by 
immunoprecipitation using a ChemiDoc XRS system and Quantity One v4.5.0 
software (Bio-Rad). The average density is normalized to the total protein 
concentration (mg/mL) of each individual sample. Right graph, serum neopterin 
concentrations (nmol/L) normalized to the respective creatinine concentration 
(μmol/L) in the samples used for Wnt5A immunoprecipitation. Data are from one 
representative of four independent experiments. p<0.05 (c) Wnt5A in sections from 
bone marrow biopsies of patients with fatal sepsis and from healthy individuals17 was 
detected by immunohistochemistry as described in Methods. As controls, sections of 
L-cells and Wnt5A cells mixed in a ratio of 10:1 were treated in the same manner. 
Photomicrographs were acquired with a Zeiss Axioskop 2 equipped with Axiocam 
MRc digital camera and Axiovision v4.4 software. Magnification, 400X (left panel) and 
640X (right panel). Arrows point to Wnt5A positive macrophages. 
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7. Conclusions  
 
APC has previously been shown to have anti-inflammatory effects on several cell 
types. However the exact mechanism of its anti-inflammatory action is still unknown. 
The results presented herein expand our knowledge on targets of APC and opens 
new lines of investigation to be explored in order to elucidate the unique properties of 
this molecule. 
In a genome wide transcriptional screen of macrophages stimulated with LPS and 
IFN-γ, we have identified Wnt5A as one of the most highly induced genes. 
Suppression of inflammation-forced Wnt5A expression by APC implicated Wnt5A in 
an active role in the inflammatory response. We confirmed regulation of Wnt5A 
protein in macrophages and detected it in sera and bone marrow macrophages of 
patients with severe sepsis. We established that a functional Wnt5A/frizzled-
5/CaMKII signaling pathway was essential for macrophage inflammatory activation. 
To prove the essential contribution of Wnt5A we measured inflammatory cytokines 
after stimulation with Wnt5A, silenced Wnt5A by siRNA, and blocked receptor binding 
with soluble Frizzled–related peptide-1 (sFRP1). This results showed that Wnt5A is 
critically involved in inflammatory macrophage signaling in sepsis and is a target for 
anti-inflammatory mediators like APC or antagonists like sFRP1. 
In conclusion this work adds new important elements to the comprehension of 
macrophage activation during local and systemic inflammation, shows new targets for 
the anti-inflammatory action of APC and may open new therapeutical ways to the 
management of inflammation. 
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